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The extent of gap junction (GJ)-mediated coupling can be modulated through GJ channel 
gating.  However, the amount of connexin protein available for incorporation into GJ, efficiency 
of channel assembly, trafficking to the cell surface, and disassembly also contribute to the 
regulation of cell-cell communication. In addition to their function in GJ, connexins also regulate 
a variety of physiological processes by forming hemichannels that are involved in paracrine 
signaling (Sanchez, Orellana et al. 2009) and through interactions with other proteins in the 
cytoplasm(Francis, Xu et al. 2011) and at the plasma membrane(Fowler, Akins et al. 2013). 
These other connexin functions are also likely to be influenced by the channel assembly 
dynamics, trafficking, and fast turnover of connexin proteins. The aim of this work was to 
determine if post-translational modifications, such as lysine acetylation, regulate connexin 
function through the fine-tuning of protein turnover or some other aspect of GJ dynamics.  
We chose to focus specifically on Cx32 for several reasons. Cx32 is an important 
regulator of neuronal myelination and loss of Cx32 GJ function is a common cause of the 
demyelinating neuropathy, Charcot-Marie-Tooth disease. Most studies addressing post-
translational modifications of connexins focus on Cx43, which shares little sequence homology 
with Cx32 in the domains that are most-often subject to post-translational modification. We 
surmised that our results could be compared to what is known about Cx43 in order to determine 
if shared post-translational modifications regulate evolutionarily divergent connexins in similar 
ways. 
Here we show that Cx32 is an acetylated protein and that acetylated Cx32 is found in the 
cytoplasm and in the plasma membrane, where it is incorporated into GJ.  For many proteins, 
acetylation has been implicated in pathways that modulate protein turnover(Caron, Boyault et al. 
2005), thus we tested whether acetylation could regulate Cx32 protein level, resulting in the 
modulation of Cx32 functions. Our results demonstrate that acetylation is a positive regulator of 
Cx32 protein level, which increases the amount of Cx32 at the cell surface. Inhibition of the 
cytoplasmic deacetylase, HDAC6, results in hyperacetylation and accumulation of Cx32, which 
is dependent upon cytoplasmic C-terminal lysines.  
Mutational analysis revealed that these C-terminal lysines influence the ubiquitination 
and turnover rate of Cx32 protein. Comparison of the subcellular localization of  WT Cx32 to 
that of mutants that either abolish acetylation sites while maintaining the original amino acid 
charge (KR) or mimic constitutive acetylation (KQ) suggests that acetylation does not 
simply alter lysine occupancy, thus preventing Cx32 ubiquitination and subsequent turnover. 
Instead, it seems likely that acetylation modulates protein-protein interactions that influence the 
amount of Cx32 in the plasma membrane and the role of Cx32 as a regulator of growth of cell 
cultures. KQ Cx32 accumulates at the cell-surface more than WT Cx32, while KR behavior 
resembles that of WT. Further, KQ Cx32 suppresses the expansion of N2a cell cultures, 
whereas WT and KR Cx32 do not.  Interestingly, none of the mutations resulted in detectable 
alterations of cell-cell communication, suggesting that the suppression of cell culture growth 
observed when cells expressed the KQ mutant may be independent of cell-cell 
communication. These results suggest that Cx32 acetylation is a positive regulator of Cx32 
mediated suppression of proliferation or enhancement of pro-apoptotic signaling and provide 
rationale for future studies to determine which protein-protein interactions are modulated 




















 Table of Contents 
 
Chapter 1  – Introduction ……………………………………………………….…………..… 1 
 Initial characterization of gap junctions ...……………………………..………….....  2  
  Ultrastructural studies of cell-cell junctions …………………..……………... 2 
  Identification of gap junctions and connexins ………………………..…….… 3 
 Connexins: the building blocks of gap junctions…………………............................... 4 
  Topology and domains ………………................................................................ 5 
  Permeability...………………...……………………………………………….….6 
 Connexin hemichannels ...………………………………………………….……………7  
  As regulators of apoptosis ………………………………...…………………….7 
  In bone ……………………………………………...……………………………8 
  Role in ischemic tissue damage …………………………………………………9 
 Connexin interacting partners ………………………………………………………….9 
  Microtubules ……………………………………………………………………..9 
  Other junction proteins ……………………………………………..…………10 
  Mitochondrial proteins ………………………………………..……………….11 
 Connexin32 as a regulator of nervous system and liver homeostasis……………….12 
  Charcot-Marie-Tooth disease …………………………………………..……..12 
  Elusive functions in liver……………………………….………………………13 
 Connexin32 as a regulator of cellular proliferation ………………..………………...14 
  Loss of function ………………………………………………………………...15 




 Post-translational modifications of Connexin32 ……………………….…………….18 
Lysine acetylation is a common post-translational modification  
with diverse consequences ……………………………………….…………………….21 
  Protein stabilization by acetylation …………………………………...23 
Objectives of study ………………………………………………………...…………...24 
Figures………………………………………………………………………..………….26 
   
Chapter 2 - Connexin 32 acetylation is regulated by HDAC6…….…………………………31 
Introduction …………………………………………………………………………….32 
Results ………………………………………………..…………………………………35 
 Cx43 localization, but not acetylation is altered by loss of HDAC6 activity.35 
 Cx32 is an acetylated protein ………………………………………………….36 
HDAC6 activity regulates Cx32 protein level and post-translational 
modifications ………………………………………………………………..…38 
C-terminal lysines influence Cx32 turnover………………………………….40 
 Figures ………………………………………………………………………………….42 
 Discussion ………………………………………………………………......................60 
 Materials and methods ………………………………………………………………...62 
 
Chapter 3- C-terminal lysines modulate Cx32 turnover and ability to suppress growth of 
cell cultures …………………………………………………………………….……………….67 
 Introduction …………………………………………………………………………….68 
Results .......................………………………………...…………………………….…...71 
 HDAC6 inhibition causes Cx32 protein accumulation ……………………...71 
 C-terminal lysines are implicated in HDAC6i response …………………….73 
ii 
 
 C-terminal lysines regulate Cx32 level at the cell surface …….……………..75 
 C-terminal lysines are dispensable for GJ function ………………………….75 
Acetylation is a modulator of Cx32 mediated suppression of cell culture 
expansion ……………………………………………………………………….76 
 Figures ………………………………………………………………………………….78 
 Discussion ……………………………………………………………………………..100 
 Materials and methods ……………………………………………………………….105 
 
Chapter 4 – Conclusions and future experiments …………………………………………112 
 Summary of conclusions …………………………………………………………….113 
Acetylation modulates Cx32 turnover and Cx32 mediated suppression of cell culture 
expansion………………………………………………………………………………114 
The consequences of Cx32 acetylation differ from those of Cx43 acetylation ……115 















 List of Figures 
 
Chapter 1 – Introduction ……………………………………………………………………….1 
 Figure 1. Images from pioneering ultrastructural studies of Gap Junctions ……...27 
Figure 2. Connexin domains and topology ……………………………..…………….28 
 Figure 3. Connexins regulate diverse physiological processes ………………………29 
Figure 4. Acetylation as a regulator of protein stability …………………………….30 
Chapter 2 - Connexin 32 acetylation is regulated by HDAC6…….…………………………31 
 Figure 1. HDAC6 regulates Cx43 localization independent of acetylation…………43 
 Figure 2. Cx32 accumulates in response to HDAC inhibition…………………….....45 
 Figure 3. Acetylated Cx32 is found in the cytoplasm and at the cell surface……….47 
 Figure 4. Cx32 accumulation after TSA and TubastatinA treatment are similar….49 
 Figure 5. HDAC6i increases Cx32 acetylation and reduces polyubiquitination …..51 
Figure 6. HDAC6 KD results in Cx32 protein accumulation and reduced 
ubiquitination………………………………………...…………………………………53 
Figure 7. Post-translational modifications of Cx32 cytoplasmic lysines are regulated 
by TSA treatment……………………………………………………………………….55 
Figure 8. K231 and K260 modulate Cx32 turn-over, but not localization………….57 
Chapter 3 - C-terminal lysines modulate Cx32 turnover and ability to suppress growth of 
cell cultures……………………………………………………………………………………...67 
 Figure 1. HDAC6 inhibition reduces turn-over and increases acetylation of Cx32..79 
Figure 2. HDAC6 inhibition results in the accumulation of both cytoplasmic and cell 
surface Cx32………………………………………………………………….…………82 
Figure 3. C-terminal lysines are implicated in HDAC6i response…………………..85 
Figure 4. C-terminal lysines influence Cx32 turn-over………...…………………….88 
Figure 5. C-terminal lysines influence Cx32 localization and HDACi response……90 
iv 
 
Figure 6. C-terminal lysine mutants form functional GJ………………………...…..92 
Figure 7. Cx32 5Q suppresses growth of N2a cell cultures ………………………….94 


























This work could not have been completed without the guidance and support of my thesis 
committee; Drs. Liz Miller, Lars Dietrich, Mona Freidin, and Peter Brink and my advisor Dr. 
Chloe Bulinski. Chloe has allowed me great freedom to pursue my interests. Liz was particularly 
instrumental in pushing me to initiate the writing process and has been quite generous with her 
time along the way. Mona has generously provided reagents and shared many stimulating 
discussions of my work.  All have contributed essential elements to my training and I truly 
appreciate the time that you have spent with me. 
I owe a great debt of gratitude to my colleagues in the Bulinski lab and beyond. Drs. 
Andy Tran and Ambar Salam in particular have been dear friends and scientific mentors. Over 
the years I have looked forward to being able to simultaneously laugh at ourselves, commiserate 
over failed experiments, and share the excitement of new data and ideas with you both. Dr. Elliot 
Hertzberg laid the foundation for my project and sparked my interest in studying Cx32. He has 
also provided technical guidance, discussion, and encouragement throughout my graduate career. 
I would also like to thank Dr. Charles Abrams for collaborating with me and carrying out a set of 
experiments that greatly enhanced the final interpretation of my work. 
I have had the great pleasure of spending my time outside of the lab with incredibly 
inspiring and supportive people as well. Jen Busse, Patrick Hynes, Ben Gutman, Natalie Kelly, 
Jonathan Stenger, and Kir Selert have all touched my life in meaningful ways and contributed to 
my ability to finish this thesis. Many other members of the NYC running and punk rock 
communities have allowed me to [temporarily of course!] escape the lab in order to enjoy our 
great city to the fullest. 
vi 
 
  Dr. Felice Kelly has pushed me to run faster, work harder, and generally strive to be a 
better person. She also spent many hours discussing and editing this thesis. Katie Casto has 
endured years of my grumbling about the trials and tribulations of graduate school and through it 
all she has overwhelmed me with her positive attitude and kindness. Thank you both for being 
the sisters that I always dreamt of having. I never could have pulled this off without you. 
Finally, this thesis is dedicated to my family; Jeanne and Morteza Alaei and Richard 
Spofford. My parents have always made it possible for me to pursue my interests and have 
focused a great deal of time and resources on my education. I may not have always shown my 
appreciation, but all of my accomplishments are a reflection of your efforts and I hope that in the 
end I will accomplish something that we can all be proud of. As for Richard, if I had met him 
any later than I did, there would be no thesis to defend because he would not have been there to 
talk me into trying to finish the work that I found altogether hopeless at the time. Your positive 
outlook and willingness to spend far too many weekend afternoons in the Fairchild Building 
made this possible. 























Initial Characterization of Gap Junctions 
A fundamental property of the tissues within the body of any multicellular organism is 
the ability for individual cells to coordinate complex physiological processes in order to act as a 
single, larger unit. Cell-cell junctions are protein complexes that mediate this coordination. 
Definitive evidence of direct cell-cell contact was first presented in 1962 by Dewey and Barr, 
who used electron microscopy to investigate the structure of smooth muscle cells(Dewey and 
Barr 1962).  They wondered how individual cells could act as though they were electrically 
connected and thus hypothesized that there must be a physical link between the cytoplasm of 
adjacent cells.  Electron microscopy revealed that neighboring cells made multiple contacts 
through their cell membranes and that the membranes were not fused in such a way that their 
cytoplasm was continuous. This meant that the cells were discrete, but likely to interact with 
each other through the points of membrane contact, which Dewey and Barr termed the nexus. 
Dewey and Barr hypothesized that the nexus included structures that allow molecules to pass 
between the cytoplasm of neighboring cells. 
Initially  studies did not distinguish between the various types of junctions that appeared 
to form at points of contact between adjacent cells(Dewey and Barr 1964). However, detailed 
ultrastructural studies of epithelia revealed that several different types of contacts exist between 
neighboring cells.  Tight junctions were identified as fusions between the membranes of adjacent 
cells, which form a sealed barrier between the cells and the extracellular space. Adherens 
junctions were identified as a zone of diffuse and homogenous material, later identified as actin 
intermediate filaments and their binding partners, that forms connections between the 
cytoskeletons of adjacent cells. Desmosomes were identified as discrete cytoplasmic plaques, 
converged upon by cytoplasmic fibrils (later identified as intermediate filaments) (Farquhar and 
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Palade 1963) (Farquhar and Palade 1965). While these cell-cell contacts seemed likely to allow 
adjacent cells to coordinate certain physical processes, they did not seem to fit Dewey and Barr’s 
description of the nexus, in that they were unlikely to allow molecules to pass between the 
cytoplasm of the cells. This function seemed most likely to be mediated by structures that were 
located within the plasma membrane and thus could form pores between the cells. 
Further characterization of cell-cell contacts at the nexus revealed that action potentials in 
smooth muscle could be propagated in vitro between cells that were aligned over an artificial gap 
that induced nexus formation(Dewey and Barr 1962; Barr, Berger et al. 1968).  Small ions were 
also shown to travel between adjacent epithelial cells, meaning that nexus function was not 
limited to excitatory cells (Loewenstein and Kanno 1964).  Fluorescein sodium was identified as 
a small molecule tracer that passed between cells, but not into the extracellular space after 
microinjection(Kanno and Loewenstein 1964). This meant that the nexus was not strictly 
involved in ion transport, but rather, it was potentially mediating the diffusional transport of a 
variety of small molecules between neighboring cells. 
 Efforts to identify the nexus continued to rely on a combination of thin sections and 
freeze fracture preparations as samples for structural analyses by electron microscopy. Using 
lanthanum as a tracer to penetrate the extracellular space, Brightman and Reese showed that a 
20-30 Å gap exists between adjacent cells from a variety of tissues (Brightman and Reese 1969). 
Hexagonal particles were visible along these gaps as they were outlined by the lanthanum.  
Freeze fracture preparation of samples for electron microscopy allowed the separation of the 
membranes of contacting cells in order to reveal the subunits of the nexus. The nexus, which has 
since been referred to as the gap junction (GJ), was thus shown to be composed of hexagonal 
macromolecular structures that appeared to be aligned between the neighboring cells(McNutt 
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and Weinstein 1970). Subsequent studies defined GJ as a polygonal lattice of subunits found 
within the cell membrane (Figure 1.), along a 20 Å gap between adjacent cells(Goodenough and 
Revel 1970; Amsterdam, Josephs et al. 1976). The hexagonal particles could be arranged at 
varying densities and sometimes unopposed on the neighboring cell membrane. The electron 
density of these particles was similar to that of the cytoplasm, rather than the membrane or 
extracellular space, further suggesting that GJ were cytoplasmic bridges(Goodenough and Revel 
1970). 
The unique morphology and low solubility of gap junctions were exploited in order to 
isolate the constituent proteins. Membranes containing GJ were purified by density gradient 
centrifugation and the use of high ionic strength detergent. Then the presence of GJ was 
confirmed by electron microscopy and X-ray defraction (Goodenough and Stoeckenius 1972).  
Initially the yield of this GJ purification was too low to carry out detailed biochemical studies of 
the GJ proteins, but subsequent improvements in solubilization and fractionation lead to the  
identification of a major GJ component from rat hepatic tissue by gel electrophoresis 
(Goodenough 1974).  This protein was named connexin, since it connects cells through nexus 
contacts.  
Connexins: the Building Blocks of Gap Junction Channels 
Studying GJ mediated cell-cell communication in a variety of cell types provided 
evidence for the existence of multiple, distinct GJ proteins. While the earliest studies of GJ 
mediated coupling focused on electrical coupling of excitatory cells and  whole tissues, 
researchers eventually showed that cultured fibroblasts also produced functional GJs, a discovery 
that allowed GJs to be studied extensively in vitro(Gilula, Reeves et al. 1972). Using cultured 
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cells and in vitro GJ communication assays, GJs were shown to be permeable to small, polar 
molecules (Flagg-Newton, Simpson et al. 1979).  Later it became clear that GJs could mediate 
the diffusion of specific complements of hydrophilic molecules such as nucleotides, small ions, 
water, and metabolites (reviewed in (Kumar and Gilula 1996)). It has been hypothesized that  
gene duplication and subsequent mutations gave rise to the variety of connexin genes that are 
found in mammalian cells(Willecke, Eiberger et al. 2002).   
Once several connexin cDNAs had been cloned, it became possible to study the function 
of each domain within a connexin molecule. All connexin proteins are four pass transmembrane 
proteins (see Figure 2. for basic topology). Two highly conserved extracellular loops mediate the 
alignment and docking of adjacent channels through disulfide bonds(Rahman and Evans 1991; 
Rahman, Carlile et al. 1993).  Short cytoplasmic N-termini are implicated in GJ oligomerization, 
gating and trafficking(Oh, Abrams et al. 2000; Purnick, Oh et al. 2000; Rouan, Lo et al. 2003; 
Gemel, Lin et al. 2006; Kyle, Minogue et al. 2008). The cytoplasmic loop impacts channel 
selectivity and gating (Wang, Li et al. 1996; Wang, Martínez et al. 2005; Xu, Kopp et al. 2012). 
Hydrophobic transmembrane residues form the pore itself and thus are important for determining 
the permeability of the GJ channel (Zhou, Pfahnl et al. 1997; Pfahnl and Dahl 1998; Skerrett, 
Aronowitz et al. 2002; Kronengold, Trexler et al. 2003). The cytoplasmic C-termini mediate 
interactions with other cytoplasmic proteins, including cytoskeletal elements, the components of 
other types of cell-cell junctions, and signaling proteins (Kumar and Gilula 1996; Yeager and 
Nicholson 1996; Giepmans and Moolenaar 1998; Giepmans, Verlaan et al. 2001; Giepmans, 
Verlaan et al. 2001; Shaw, Fay et al. 2007).  While the amino acid sequences of N-termini, 
transmembrane domains, and extracellular loops of connexins are highly conserved, the 
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cytoplasmic loops and C-termini are more divergent. The sequences found in these divergent 
domains confer unique permeability and interacting factor compliments for each connexin. 
Six connexin subunits oligomerize in order to form a hemichannel, which is transported 
to the cell surface and inserted in the plasma membrane. Each of the cells within a coupled cell 
pair then contributes a hemichannel and the GJ is formed when the adjacent hemichannels align 
to form a pore between neighboring cells(Yeager and Nicholson 1996; Yeager, Unger et al. 
1998).  The hemichannels are composed of either a single type or a combination of two 
compatible connexins. GJ may are then composed of the same hemichannel types or 
hemichannels with different compositions (Swenson, Jordan et al. 1989; Werner, Levine et al. 
1989). Each connexin combination gives rise to a GJ with particular permeability characteristics, 
which can be enhanced or reduced depending on the connexin combination(Beyer, Gemel et al. 
2001; Martinez, Hayrapetyan et al. 2003; Gemel, Valiunas et al. 2004; Martínez, Maripillán et al. 
2011). Tissue specific GJ permeability thus depends upon connexin specific oligomerization 
properties and cell type specific connexin expression profiles. 
Molecules pass through open GJ channels by passive diffusion unless GJ gating is 
induced by stimuli such as increased transjunctional voltage, intracellular acidification, or 
increased intracellular [Ca2+] (Dahl 1996). Residues in the N-terminal(Verselis, Ginter et al. 
1994), extracellular1 (Rubin, Verselis et al. 1992), transmembrane2(Suchyna, Xu et al. 1993) 
and  C-terminal (Moreno, Chanson et al. 2002) domains of various connexins have been 
implicated in voltage gating. Connexins vary in their pH sensitivity, but gating due to cellular 
acidification is generally facilitated by the intracellular loop and C-terminal domains (Ek-
Vitorin, Calero et al. 1996; Francis, Stergiopoulos et al. 1999; Eckert 2002). Chemical gating of 
GJ occurs in the presence of high concentrations of Ca2+,  which results in the  loss of 
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calmodulin binding in some cases(Dodd, Peracchia et al. 2008) (Hertzberg and Van Eldik 1987). 
Interestingly, electrophysiological analyses of GJ activity, correlated with high resolution image 
analysis of GJ size revealed that only a small fraction of total GJ at the cell surface are open at 
any point in time(Curti, Hoge et al. 2012). This suggests that GJ mediated cell-cell 
communication is regulated in large part by pathways that are independent of the aforementioned 
GJ gating. Also, it suggests that GJ associated connexins may be involved in physiological 
pathways that function independently of cell-cell communication (Figure 3.). These possibilities 
are discussed throughout this thesis. 
Connexin Hemichannels 
 Connexins exist in several distinct cellular pools, which include GJ, hemichannels within 
the plasma membrane, and hemichannels within the secretory system and cytoplasm. While most 
work to date has focused upon the physiological consequences of GJ function, there is mounting 
evidence that non-junctional hemichannels are also physiologically relevant.  Connexin 
hemichannels are permeable to a variety of molecules such as glutamate (Orellana, Froger et al. 
2011), NAD+ (Okuda, Nishida et al. 2013), prostaglandin E2(Cherian, Siller-Jackson et al. 
2005), Ca2+ (De Bock, Wang et al. 2012), and ATP(Kang, Kang et al. 2008),which are involved 
in paracrine signaling. The passage of molecules through connexin hemichannels regulates 
processes such as apoptotic cell death (Vinken, Decrock et al. 2010; Kameritsch, Khandoga et al. 
2013)  and bone remodeling in response to mechanical stress(Jiang and Cherian 2003) . It also 
seems likely that some studies that have identified GJ as regulators of processes such as 
tumorigenesis overlooked the regulatory contributions of hemichannels. 
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A number of recent studies have shown that connexin hemichannels are involved in the 
regulation of apoptosis. Vinken and colleagues observed that during apoptosis GJ-mediated 
coupling decreased, despite increased plasma membrane associated Cx32, suggesting a shift 
from GJ to hemichannel Cx32 function apoptosis (Vinken, Decrock et al. 2010). Inhibition of 
Cx32 hemichannels decreased cell death in response to pharmacological activators of apoptosis, 
providing evidence that Cx32 hemichannels are positive regulators of apoptosis. A decrease in 
junctional Cx43 and GJ-mediated communication has also been observed during apoptosis in 
lens epithelium and cultured fibroblasts (Theiss, Mazur et al. 2007).  Inhibition of Cx43 
hemichannels by antibody binding, mimetic peptides, or general pharmacological inhibition of 
GJ attenuated pro-apoptotic Ca2+ signaling in HeLa cells transfected with Cx43 cDNA, and  
HL-1 or freshly isolated cardiomyocytes, which both express endogenous Cx43 (Verma, Hallett 
et al. 2009).   
Cx43 hemichannels have been implicated in bone remodeling, which results from 
mechanical stress and is important for healthy bone maintenance. Cx43 hemichannels are 
permeable to prostaglandins, which are paracrine signaling molecules that regulate bone 
remodeling. Osteocyte processes have been shown to act as mechanotransducers that open 
connexin hemichannels (Burra, Nicolella et al. 2010). Mechanical loading of osteocytes induces 
prostaglandin release via Cx43 hemichannels(Siller-Jackson, Burra et al. 2008). Inhibition of 
Cx43 channel activity results in decreased prostaglandin release when cells are subjected to shear 
stress. Cx43 protein level and localization also seems to be modulated by shear stress, since cell 
surface Cx43 level increases in response to shear stress, which results in increased prostaglandin 
release (Cherian, Siller-Jackson et al. 2005). The plating density of Cx43 expressing osteocytes 
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also modulates prostaglandin release. As cell density decreases and Cx43 is shifted from GJ to 
hemichannels, prostaglandin release increases. 
 Connexin hemichannels are also involved in tissue damage that occurs as a consequence 
of ischemia and reperfusion.  Metabolic inhibition is used to model ischemia and reperfusion in 
vitro. Induction of hemichannel opening in HeLa cells expressing exogenous Cx32 occurred as a 
result of metabolic inhibition (Sanchez, Orellana et al. 2009).  Ischemia also induced closing of 
GJ and opening of hemichannels in cardiac myofibroblasts in vitro(Johansen, Cruciani et al. 
2011).  Since cell death is associated with the flux of Ca2+ and other signaling molecules 
through connexin hemichannels that occurs with reperfusion, Wang et al. hypothesized that 
treating ischemic mice with a hemichannel specific inhibitor could protect against tissue injury 
during reperfusion(Wang, De Vuyst et al. 2013). GAP19 was developed and tested for Cx43 
hemichannel specificity and does not inhibit GJ activity. Treatment with GAP19 inhibited the 
opening of hemichannels after metabolic inhibition in HeLa cells expressing exogenous Cx43, 
reduced cell death due in cardiomyocytes subjected to hypoxia, and also reduced infarct size in 
vivo in mouse hearts after ischemia and reperfusion. Taken together, these data provide evidence 
that metabolic regulation of connexin hemichannels is likely to be a common theme amongst 
members of the connexin protein family.  
Connexin Interacting Partners  
Connexins are also involved in protein-protein interactions that have physiological 
consequences that are independent of GJ or hemichannel functions. For example, Cx43 regulates 
cell motility in a manner that seems to be independent of cell-cell communication and 
hemichannel function (Francis, Xu et al. 2011). Ablation of the Cx43 gene results in neonatal 
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lethal heart defects that have been linked to a cell motility defect in neural crest cells(Xu, Francis 
et al. 2006). This cell motility defect can be reversed by expression of exogenous Cx43. 
Expression of a Cx43 mutant that forms non-functional GJ also rescues the motility defect, while 
expression  of Cx43 lacking a microtubule binding motif does not(Francis, Xu et al. 2011).   
Cx43 also interacts with other junctional proteins, enhancing the formation of cell-cell 
junctions in a way that may be independent of GJ or hemichannel function. For example, Cx43 
interacts with tight junction proteins ZO-1 and Occludin-1 and may be required for tight junction 
maintenance of the blood-brain barrier(Nagasawa, Chiba et al. 2006). These interactions occur 
through a PDZ motif found in the C-terminus of Cx43, a region of the protein that is not 
involved in GJ function(Giepmans, Verlaan et al. 2001). Interaction of Cx43 with β-catenin is 
associated with increased adherens junction localization of β-catenin and decreased transcription 
factor activity (Ai, Fischer et al. 2000). N-cadherin, another adherens junction protein, has been 
isolated as part of a multi-protein complex with Cx43(Wei, Francis et al. 2005).  Depletion of N-
cadherin protein in cultured fibroblasts prevented Cx43 GJ formation, and depletion of Cx43 
resulted in reduced N-cadherin associated with adherens junctions. The interaction of a 
desmosomal protein, Plakophilin-2, with Cx43 acts as a positive regulator of cell adhesion in an 
in vitro model of the blood-testis barrier(Li, Mruk et al. 2009). Taken together, these studies 
suggest that GJ and other cell-cell junctions interact physically in order to promote cell-cell 
adhesion as a whole.  
Less is known about the interacting partners of Cx32. Cx32 lacks the PDZ motif that is 
found in Cx43 and other proteins that bind to scaffold proteins such as ZO-1. However, Cx32 co-
immunoprecipitates with complexes containing tight junction proteins including Zo-1, occludin, 
and claudin-1(Kojima, Kokai et al. 2001). These proteins also colocalize with Cx32 in freeze-
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fracture replicas of cultured rat hepatocytes. Expression of exogenous Cx32 in a hepatocyte cell 
line that lacked endogenous connexins induced tight junction formation, suggesting that the 
interactions between Cx32 and tight junction proteins may function in the formation or 
stabilization of tight junctions (Kojima, Sawada et al. 1999).  Cx32 also interacts with the 
membrane associated scaffold protein, Dlgh-1 (Discs large homology-1), which can act as a 
tumor suppressor (Duffy, Iacobas et al. 2007). Dlgh-1 plasma membrane localization and protein 
level were enhanced by expression of exogenous Cx32 in a connexin deficient cell line and 
decreased in hepatocytes derived from Cx32 null mice compared to those from Cx32 expressing 
mice.  
A recent proteomic study led to the isolation of liver Cx32 associated with endoplasmic 
reticulum resident, cytoplasmic, plasma membrane associated, and mitochondrial proteins  
(Fowler, Akins et al. 2013). Cx26 was associated with Cx32 at the plasma membrane and loss of 
Cx32 resulted in reduced Cx26 protein, suggesting that Cx32 stabilizes Cx26 protein. Among the 
isolated interacting proteins, sideroflexin-1, is a mitochondrial protein that was isolated with both 
mitochondrial and plasma membrane associated Cx32. Based upon the comparison of 
sideroflexin-1 localization in Cx32 null and Cx32 WT hepatocytes, the authors suggested that 
Cx32 interacts with mitochondrial sideroflexin-1 at the plasma membrane, resulting tethering of 
mitochondria to the plasma membrane. This is a novel interaction that could explain the 
detection  of mitochondrial Cx43 localization as well (Boengler, Dodoni et al. 2005; Trudeau, 
Muto et al. 2012).  The interactions between connexins and mitochondrial proteins could provide 
a link between connexins and cellular metabolism that is independent of connexin channel 
function and instead dependent upon the subcellular localization and cytoplasmic amino acid 
sequences of the connexins. 
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Cx32 as a Regulator of Nervous System and Liver Homeostasis 
Cx32 is an important regulator of neuronal and liver homeostasis.  The physiological role 
of Cx32 expression has been studied in the most detail in hepatocytes and glia where it is most 
abundant. However, Cx32 is also expressed in the lungs, kidney, prostate, stomach, and small 
intestine (Paul 1986; Mehta, Perez-Stable et al. 1999; King and Lampe 2004). Cx32 mediated 
cell-cell communication plays a role in sympathetic nerve function in the liver (Nelles, Butzler et 
al. 1996), as well as peripheral nerve function(Scherer, Xu et al. 1998). Mutations that reduce or 
eliminate Cx32 function result in peripheral neuropathy(Abrams, Freidin et al. 2001).  In the 
liver, Cx32 has been implicated as a regulation of processes such as tumorigenesis (Temme, 
Buchmann et al. 1997) and sensitivity to chemical toxicity (Patel, Milwid et al. 2012).  
Chromosomal mapping of mutations associated with the hereditary demyelinating 
neuropathy, Charcot-Marie-Tooth disease(CMT), identified Cx32 as a regulator of peripheral 
nerve physiology(Bergoffen, Scherer et al. 1993). CMT is a common neurodegenerative disease 
with symptoms that include muscle wasting and sensory loss in the distal extremities. Mutations 
in a large and varied group of genes have been identified in CMT patients. Cx32 mutations cause 
a dominant X-linked form of CMT and represents roughly 10% of total CMT patients(Kleopa, 
Abrams et al. 2012). CMT associated Cx32 mutations are usually point mutations that effect 
hemichannel formation and trafficking the cell surface, Cx32 stability, or GJ gating (Ressot, 
Gomes et al. 1998). 
Analysis of Cx32 expression in oligodendrocytes and Schwann cells revealed that the 
timing and localization of Cx32 expression are regulated in parallel with other myelin-related 
proteins(Scherer, Deschenes et al. 1995). Both oligodendrocytes and Schwann cells are glial 
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cells, which function in the maintenance of neuronal myelinated sheaths. Oligodendrocytes 
maintain neurons in the Central Nervous System, while Schwann cells function in the Peripheral 
Nervous System. The existence of functional GJ within the myelin sheath that is formed by 
Schwann cells has been demonstrated  ex vivo(Balice-Gordon, Bone et al. 1998). Further, Cx32 
GJ have been detected between myelin layers, where they may provide short-distance radial 
pathways for the transfer of metabolites and water through the myelin sheath(Meier, Dermietzel 
et al. 2004).  These observations suggest that Schwann cell GJs may be involved in maintaining 
the myelin sheath, independent of coupling with other cells. Consistent with this possibility, 
Cx32 null mice develop normally but suffer from demyelination of  peripheral nerves over the 
course of their lives (Scherer, Xu et al. 1998). Based upon the peripheral nerve specific 
phenotype observed in Cx32 null mice, it seemed likely that loss of Cx32 function in Schwann 
cells is the underlying cause of CMTX-1. This hypothesis was supported by the observation that 
expression of a Cx32 transgene driven by a Schwann cell specific promoter was sufficient to 
prevent peripheral nerve demyelination in Cx32 null mice (Scherer, Xu et al. 2005).   
Cx32 does not play an essential role during liver development, as evidenced by normal 
liver development in Cx32 null mice(Evert, Ott et al. 2002). While the livers of Cx32 null mice  
are structurally normal, further investigation revealed that sympathetic nerve stimulation of bile 
secretion is impaired in Cx32 null mice(Temme, Stumpel et al. 2001). Glucose mobilization by 
the liver is significantly lower in Cx32 null mice than WT, also due to a defect in sympathetic 
nerve stimulation of the liver(Nelles, Butzler et al. 1996). Further, Cx32 function has been 
implicated in hepatic stress hormone response, which depends upon coordination of Ca2+ 
signaling (Correa, Guerra et al. 2004).  Ca2+ signaling is not inhibited in Cx32 null cells, but 
there is a marked delay in the propagation of Ca2+ release signals in the absence of Cx32.  Loss 
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of Cx32 expression  is also associated with an increased incidence of chemical and radiation 
induced tumorigenesis in the liver(Tsuda, Asamoto et al. 1995).  
GJ have been implicated in pro-inflammatory pathways such as the DNA-triggered innate 
immune response(Patel, King et al. 2009). The DNA-triggered innate immune response refers to 
the sensing of exogenous DNA and subsequent activation of immune cells, which secrete 
cytokines and antiviral molecules. The inflammatory response is propagated across a tissue via 
GJ communication and thus, inhibition of GJs reduces inflammation but could also enhance 
infection.  While this study did not specify which GJ were involved in the propagation of  
inflammatory signals, other work has implicated Cx32 as a negative regulator of vascular  
inflammation through its regulation of cytokine expression  (Okamoto, Akiyama et al. 2011). 
Still other work has implicated Cx32 in the propagation of tissue damage that occurs with tissue 
damage in the liver. Inhibition of Cx32 with a novel specific inhibitor has been shown to reduce 
liver damage that results from drug toxicity(Patel, Milwid et al. 2012). Transgenic mice 
expressing a dominant negative Cx32 mutant are also resistant to chemically induced liver 
damage (Asamoto, Hokaiwado et al. 2004).   
Taken together, these studies show that Cx32 is implicated in a variety of physiological 
processes which are cell type and context dependent.  Additionally, Cx32 GJ are likely to 
regulate tissue homeostasis through pathways that are independent of cell-cell communication in 
some cases.  
Cx32 as a Regulator of Cellular Proliferation 
Several different experimental approaches have generated data that suggest a role for 
Cx32 in tumor suppression. Analyses of human and murine tumor sample support the claim that 
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Cx32 is a tumor suppressor protein. Reduced Cx32 expression has been detected in both murine 
and human gastric carcinomas, where Cx32 expression level relates inversely to the severity of 
the tumor(Jee, Nam et al. 2011). Cx32 expression was significantly reduced after carcinogen 
exposure in mouse models of liver tumorigenesis (Fitzgerald, Mesnil et al. 1989). A study 
following the course of chemically induced tumor progression in mouse livers revealed that 
Cx32 protein level is inversely related to tumor cell proliferation rate (Tsuda, Asamoto et al. 
1995).Cx32 expression is also correlated with human lung cancer prognosis; higher Cx32 
expression levels correspond to better prognosis(Zhang, Li et al. 2009). 
Loss of GJ by cancer cells was first observed in hepatocytes over 40 years ago 
(Loewenstein and Kanno 1967). Genetic ablation of Cx32 increased spontaneous, chemical, and 
radiation induced tumorigenesis in the liver when compared to Cx32 expressing tissue (Temme, 
Buchmann et al. 1997). Further investigation of radiation induced tumorigenesis revealed that the 
overall tumor load was increased in Cx32 null mice, compared to wild-type, and that liver, lung, 
intestinal, lymph, and adrenal tumors were most prevalent(King and Lampe 2004).  Thyroid 
tissue in the Cx32 null mouse also exhibited increased cellular proliferation under growth 
promoting conditions, which could be inhibited by restoration of Cx32 expression(Prost, 
Bernier-Valentin et al. 2008). Irradiation resulted in increased activation of the oncogenic MAP 
kinase pathway in Cx32 null mice, compared to the WT (King and Lampe 2004). When Cx32 
null mice were crossed with mice lacking the p27 tumor suppressor gene, the resulting mouse 
(p27 and Cx32 null) was even more susceptible to radiation induced tumor development than the 
Cx32 null mouse(King, Gurley et al. 2005). This result further implicated the MAP kinase 
pathway, which p27 is a part of, as a target of Cx32 mediated tumor suppression.  
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Connexin deficient cell lines have also been used to study the growth suppressive 
function of Cx32. For example; normal prostate cells and well differentiated prostate tumor cells  
have higher Cx32 expression levels than poorly differentiated prostate tumor cells, suggesting 
that loss of Cx32 expression may be important for prostate tumor progression(Mehta, Perez-
Stable et al. 1999).  Forced expression of Cx32 in the poorly differentiated prostate tumor cells 
slowed growth. Similarly, another study established the existence of an inverse relationship 
between Cx32 protein level and proliferation in a rat hepatoma cell line (Edwards, Jondhale et al. 
2008). Other tumor-derived cell lines from tissues such as liver and kidney have also been 
reported to express lower levels of Cx32 than their non-tumorigenic counterparts (Ma, Ma et al. 
2002; Fujimoto, Sato et al. 2005).  
The tumor suppressive role of Cx32 is likely context-dependent since there are several 
documented cases where Cx32 expression fails to reduce tumor development or even seems to 
enhance cellular proliferation. For example, expression of Cx32 in the GJ-deficient HeLa cell 
line is not sufficient to suppress tumorigenic growth (Omori and Yamasaki 1999). In another 
study, expression of a dominant negative Cx32 mutant in liver cells reduced GJ mediated cell-
cell communication, but did not increase the incidence of spontaneous tumor formation. In fact, 
in this context loss of Cx32 function enhanced tissue regeneration after hepatic injury, suggesting 
that Cx32 can function in both positive and negative regulation of proliferation(Omori, Zaidan 
Dagli et al. 2001). In a mouse model of hepatic tumor development, animals were treated with 
phenobarbital to promote tumor formation and Cx32 null mice showed reduced tumor formation 
compared to WT (Moennikes, Buchmann et al. 2000; Schwarz, Wanke et al. 2003). This result 
suggests that Cx32 is involved in phenobarbital induced tumorigenesis. 
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 Spurious expression of Cx32 was detected in some human granulosa cell tumors (Lucke, 
Siebert et al. 2010). These tumors are derived from ovarian tissue and usually express Cx43, 
which is lost or reduced in the tumors, and not Cx32. Perhaps the aberrant expression of Cx32 
does not permit cell-cell communication and instead alters cytoplasmic signaling or the Cx32 
containing GJ allow cell-cell communication that promotes proliferation. Another recent report 
suggests that a shift from plasma membrane to cytoplasmic localization of Cx32 may promote 
proliferation in adenocarcinoma cells (Kanczuga-Koda, Koda et al. 2010). A shift from 
junctional to cytoplasmic Cx32 localization has also been detected in mouse gastric metaplasia 
(Jee, Nam et al. 2011) and hepatic cancer stem cells (Kawasaki, Omori et al. 2011). Experiments 
that tested the role of Cx32 mediated cell-cell coupling in Schwann cell growth factor response 
showed that Cx32 is involved in a proliferative response that is independent of  its role in GJ 
coupling (Freidin, Asche et al. 2009), suggesting that Schwann cell proliferation may also be 
enhanced by a cytoplasmic Cx32 pool. 
Taken together, these studies suggest that Cx32 is involved in several distinct pathways 
that regulate cellular proliferation. Loss of Cx32 expression in tissues that usually express a high 
level of GJ associated Cx32 is associated with increased proliferation. This suggests that Cx32 
mediated cell-cell communication may be a negative regulator of proliferation. Aberrant 
expression of Cx32 in a tissue where it is not the primary connexin may enhance proliferation. 
This could involve altered regulation of GJ coupling and/or cytoplasmic signaling through Cx32. 
Finally, the cytoplasmic pool of Cx32 may be a positive regulator of proliferation under normal 
physiological conditions and during tumorigenesis.  
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Post-translational modifications of Cx32 
 Phosphorylation of Cx32 was first detected based on the observation that treating cells 
with membrane permeant cAMP derivatives increased cell-cell communication between 
hepatocytes in vitro. This finding prompted the incubation of hepatocytes with 32-P, which 
allowed the detection of phosphorylated Cx32 (Saez, Spray et al. 1986).  Following the detection 
of Cx32 phosphorylation, several candidate kinases were tested for their ability to increase Cx32 
phosphorylation. cAMP-dependent kinase, protein kinase C, and Ca2+/calmodulin-dependent 
kinase II phosphorylated Cx32, but not Cx26 in vitro (Saez, Nairn et al. 1990). Peptide mapping 
of the phosphorylation sites indicated that phosphorylation occurred primarily on serine residues 
and that they are located in the C-terminus of Cx32. Protein kinase C mediated phosphorylation 
of Cx32 was shown to prevent proteolysis in vitro, but the physiological relevance remains 
unclear (Elvira, Diez et al. 1993). Tyrosine phosphorylation of Cx32, mediated by epidermal 
growth factor receptor tyrosine kinase, has also been detected in vitro (Diez, Elvira et al. 1998).  
Increased Cx32 serine phosphorylation was detected after treatment with nafenopin, 
which is a hepatocarcinogen (Elcock, Deag et al. 2000). This increase in phosphorylation was 
associated with decreased Cx32 GJ function, while Cx32 protein level and localization were 
unaltered, suggesting that the phosphorylation was causing GJ closure. Treatment with a serine 
kinase inhibitor, but not a tyrosine kinase inhibitor, prevented the decrease in cell-cell coupling 
that was caused by nafenopin treatment. These findings are similar to what was shown for cAMP 
activated Cx32 phosphorylation. Other studies have linked Cx32 MAP kinase activity to Cx32 
protein level and GJ localization, but it is unclear if Cx32 is regulated directly by its own 
phosphorylation or the phosphorylation of an interacting protein(Kojima, Yamamoto et al. 2004). 
Overall, the literature addressing the physiological consequences of Cx32 phosphorylation is 
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lacking very many data that show direct interactions between Cx32 and kinases in vivo. 
However, it is clear that phosphorylation influences Cx32 GJ function.  
Ubiquitination, which entails the covalent attachment of one or more molecules of the 76-
amino acid ubiquitin protein, has been implicated in the regulation of Cx32 stability. Roughly 
50% of newly synthesized wild type Cx43 and Cx32 are degraded prior to trafficking to the 
plasma membrane under steady state conditions(Kelly, VanSlyke et al. 2007). Kelly et al. 
showed that these connexin molecules are degraded through ER-associated degradation (ERAD), 
which is mediated by the 26-S proteasome, after translocation of target proteins from the ER. 
Thus, treatment with proteasome inhibitors, increases GJ-mediated cell-cell communication by 
stabilizing a large amount of connexin protein early the transport pathway. Interestingly, mild 
cytosolic stress, such as brief hyperthermia or exposure to mild oxidative denaturants, results in 
increased connexin stability and cell-cell communication (VanSlyke and Musil 2002). This is 
specific to cytosolic stress, as treatment with inducers of ER stress, such as DTT, does not 
stabilize the nascent connexin molecules. The authors of this study hypothesized that the 
connexins are stabilized under mild cytosolic stress conditions because proteasomes are 
preferentially targeting misfolded cytosolic proteins, and thus a larger portion of newly 
synthesized connexins escape degradation and are ultimately incorporated into GJs. 
Currently, it is unknown how cell surface Cx32 is internalized and degraded. However, 
many recent studies have addressed the internalization of cell surface Cx43 and its regulation by 
Ubiquitination. Nedd4, an E3 ubiquitin ligase, was initially shown to associate with Cx43 and act 
as a negative regulator of  GJ associated Cx43 level(Leykauf, Salek et al. 2006). Subsequent 
experiments have established Nedd4 as acting directly on Cx43 in order to regulate its 
internalization via mono-ubiquitination(Girao, Catarino et al. 2009). Nedd4  mediated 
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ubiquitination of Cx43 results in its association with the ubiquitin binding protein, EPS15, which 
ultimately leads to Cx43 internalization(Girao, Catarino et al. 2009).  A recent study has 
suggested that EPS15/Nedd4 mediated Cx43 degradation occurs by macroautophagy(Bejarano, 
Girao et al. 2012).  Live cell imaging and ultrastructural data suggest that connexins from the cell 
surface are frequently degraded by macroautophagy(Lichtenstein, Minogue et al. 2011; Fong, 
Kells et al. 2012), while other studies have implicated the endocytic pathway(Naus, Hearn et al. 
1993; Leithe, Kjenseth et al. 2009; Catarino, Ramalho et al. 2011)Given that  not all of the cell-
surface localized connexin is incorporated into GJ plaques, perhaps GJs and connexin hemi-
channels are internalized and degraded through separate pathways.  This is a particularly 
intriguing possibility since GJs are internalized as large, double membrane vesicles by one 
member of the cell-pair (Amsterdam, Josephs et al. 1976; Jordan, Chodock et al. 2001; Piehl, 
Lehmann et al. 2007), whereas a hemichannel would be enclosed in a single membrane.    
SUMOylation entails the covalent attachment of ubiquitin-like proteins to a substrate, 
which often regulates substrate degradation. Two SUMOylation sites have been identified  in 
Cx43 (Kjenseth, Fykerud et al. 2012). They are located at K144 and K237, which are both 
cytoplasmic, but membrane proximal residues. Mutations at these residues decreased CX43 
protein level overall and especially at cell-cell junctions, suggesting that SUMOylation is a 
negative regulator of Cx43 turn-over. Cx43 K144, which is located in the cytoplasmic loop, 
shares a high level of sequence homology with Cx32 K124. The authors predicted that K124 of 
Cx32 is also a SUMOylation site and that this post-translational modification is another common 
post-translational modification of connexin protein family overall.  
 Prenylation, which is the addition of prenyl lipid groups, is another reported post-
translational modification of Cx32(Huang, Sirkowski et al. 2005). This lipidation occurs at 
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consensus sites and can modulate membrane protein stability and/or function through the 
modulation of protein-protein and protein-membrane interactions. Cx32 has two consensus 
prenylation sites, C280 and S281. WT Cx32 prenylation was demonstrated in cultured cells by 
incorporation of 3H- mevalonolactone, whereas Cx32 C280G and S281x mutants were not 
labeled with the 3H-mavalonolactone. Microscopic investigation revealed that the prenylation 
deficient Cx32 mutants did not appear to have trafficking or stability defects. Further, both of the 
mutants seemed to rescue the neuronal defects associated found in Cx32 null mice, suggesting 
that prenylation is not necessary for Cx32 function in myelinating Schwann cells.  
 While Cx32 was the first GJ protein identified, nearly 40 years ago, we know relatively 
little about the post-translational modifications that modulate its physiological activity. The 
studies referenced here suggest that there is much more to be learned about post-translational 
modifications of Cx32. These studies also indicate that most post-translational modifications of 
connexins occur on cytoplasmic residues in the most variable regions of connexin proteins, and 
thus it is unlikely that we can simply assume that what we know about Cx43 post-translational 
modifications can be assumed true for other connexins. 
Lysine acetylation is a common post-translational modification with diverse consequences 
  The experiments described in this thesis were designed around the central hypothesis that 
lysine acetylation of Cx32 contributes to the fine-tuning of Cx32 function. Lysine acetylation is a 
reversible, covalent, modification that occurs post-translationally on epsilon-amino groups. 
Lysine acetylation is distinct from N-terminal acetylation that occurs co-translationally on alpha-
amino groups. Note that this thesis deals exclusively with lysine acetylation when referring to 
‘acetylation’.  
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While acetylation was initially assumed to occur primarily within the nucleus, it is 
becoming increasingly obvious that lysine acetylation is a common regulator of proteins in all 
cellular compartments. Recent proteomic screens have identified acetylated lysine residues in 
thousands of proteins that are involved in diverse physiological processes (Kim, Sprung et al. 
2006; Shepard, Tuma et al. 2010; Lundby, Lage et al. 2012; Pehar, Lehnus et al. 2012). Further, 
one of these studies provides evidence for the existence of tissue specific consensus acetylation 
sites(Lundby, Lage et al. 2012).  This result suggests that tissue specific networks of enzymes 
and interacting factors would be involved in selecting proteins for acetylation, thus it follows that 
acetylation could act as a tissue specific regulator of the biochemical properties of a potentially 
acetylated protein. 
Acetylation is regulated directly by acetyltransferases that covalently attach the acetyl 
group from acetyl-Co-A to the target substrate and deacetylases (referred to as histone 
deacetylases or HDACs regardless of substrate specificity) which reverse the modification. We 
are just beginning to amass information about the specificities of acetyltransferases that modify 
proteins other than histones.  Acetyltransferases such as PCAF(Blanco-Garcia, Asensio-Juan et 
al. 2009), CBP (Kwok, Liu et al. 2006), and Tip60(Hass and Yankner 2005) shuttle between the 
nucleus and cytoplasm and have substrates in both compartments. Endoplasmic reticulum 
resident acetyltransferases such as ATase1 and ATase2 have also been identified (Ko and 
Puglielli 2009). Mitochondria also contain an abundance of acetylated proteins (Kim, Sprung et 
al. 2006) and thus the discovery of mitochondrial acetyltransferases is likely forthcoming. 
Deacetylases fall into two major catagories; NAD+ dependent Sirtuins and Zn2+ dependent 
HDACs. Sirtuins often deacetylate proteins that are involved in metabolic regulation and have 
been detected in the nucleus, cytoplasm and recently in the mitochondria (Schlicker, Gertz et al. 
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2008; Houtkooper, Pirinen et al. 2012). The HDAC family includes four classes that are defined 
by their homology to the yeast deacetylases RPD3 (class I, IV) and HDA1 (class IIa, IIb, IV).  
While the HDACs were initially assumed to be nuclear proteins, it is becoming increasingly 
clear that most of them shuttle between the nucleus and cytoplasm. 
Acetylation alters diverse biochemical properties of proteins through a variety of 
mechanisms (Figure 4.). Enzymatic activity(Lundby, Lage et al. 2012), subcellular 
localization(Gay, Calvo et al. 2003), and protein-protein interactions(Levy, Wei et al. 2004) can 
all be regulated by acetylation. Here we focus on the role of acetylation as a regulator of protein 
turnover. Protein turnover can be regulated by acetylation through competition with 
ubiquitination for lysine occupancy(Gronroos, Hellman et al. 2002; Ito, Kawaguchi et al. 2002), 
alteration of the higher order structure of protein-protein interaction sites(Choudhary, Kumar et 
al. 2009), or through interaction with acetyltransferases or deacetylases that have intrinsic 
ubiquitin-binding or –ligase activities(Hook, Orian et al. 2002; Linares, Kiernan et al. 2007).  
 Reduced acetylation has been detected in cancer cells, where it can impact tumorigenesis 
through diverse mechanisms. For example, mutations and deletions of the p300 acetyltransferase 
gene occur frequently in B-cell Non-Hodgkins Lymphoma and result in decreased acetylation 
and stability of the tumor suppressor protein, p53(Pasqualucci, Dominguez-Sola et al. 2011). 
Another recent report identified an acetylation site that inhibits the activity of lactate 
dehydrogenase A, a protein that is often overexpressed in tumor cells, contributing to an increase 
in glucose metabolism that enables increased proliferation(Zhao, Zou et al. 2013).  This 
acetylation which regulates cellular metabolism and proliferation was notably decreased in 
pancreatic tumor cells, suggesting that reduced acetyltransferase or increased deacetylase activity 
was contributing to the tumorigenicity of the cells.  Overexpression of the microtubule 
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deacetylase, HDAC6, results in decreased microtubule acetylation and increased cell motility in 
vitro(Hubbert, Guardiola et al. 2002). Interestingly, decreased microtubule acetylation has been 
detected in prostate cancer cells compared to normal prostate cells, implicating MT acetylation in 
tumor cell biology as well (Soucek, Kamaid et al. 2006). In contrast to these examples of 
decreased acetylation, some recent studies suggest that global hyperacetylation is associated with 
pathological states such as cardiomyopathy (Colussi, Rosati et al. 2011; Vadvalkar, Baily et al. 
2013) . As we learn more about the regulators of non-histone protein acetylation, it seems likely 
that both positive and negative regulators of acetylation will continue to be tested as targets for 
novel drug development to combat a variety diseases.  
Objectives of this study 
While many membrane proteins have long half- lives of  24 hours or more (Chu and 
Doyle 1985), connexins have reported half- lives for 30 minutes to 5.0 hours in tissue and 
cultured cells (Fallon and Goodenough 1981; Zhang and Nicholson 1989; Laird 1991 ; 
Beardslee, Laing et al. 1998).  This discrepancy between the half- lives of other gated channel 
proteins and connexins is surprising and suggests that GJ mediated communication level is not 
strictly dependent upon the regulation of channel gating. Alterations in connexin gene 
transcription or protein stability could result in significant changes in GJ activity by altering the 
amount of connexin protein that is available for incorporation into GJ plaques. Alterations in 
trafficking or interactions with interacting proteins could also modulate GJ function and/or non-
junctional connexin functions. Post-translational modifications are often involved in the fine 
tuning of protein function through the regulation of protein stability and protein-protein 
interactions, and are thus are likely to be important regulators of connexins within GJ and in 
other physiological contexts. 
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Here we report that Cx32 is an acetylated protein and show the results of experiments 
that were conducted in order to determine the physiological significance of Cx32 acetylation. 
Specifically, we asked whether acetylation could modulate the turn-over, subcellular 
localization, and/or GJ function of Cx32. Pharmacological inhibition of deacetylase activity was 
utilized as a tool to enrich for acetylated Cx32 and also implicated HDAC6 as a regulator of 
Cx32 turn-over, through modulation of Cx32 acetylation. Our results suggest that acetylation is a 
positive regulator of Cx32 protein stability. Analysis of Cx32 mutants that mimicked constitutive 
acetylation suggested that reducing Cx32 turn-over through acetylation increases the amount of 
Cx32 at the cell surface. Increasing cell surface Cx32 levels did not result in a detectable 
increase in GJ-mediated intercellular communication, but was accompanied by reduced cellular 
proliferation in our model system. These results provide the framework for future investigation 
of protein-protein interactions that are modulated by Cx32 acetylation and physiological events 

















Chapter 1- Figures   
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Figure 1. Electron microscopy revealed the ultrastructure of gap junctions. 
Goodenough and Revel (1970) identified GJ as hexagonal particles (right image)  that 
align at varying densities along a 20 Å gap between adjacent cells (left image) . 




























Figure 2. Schematic of connexin protein topology. (A.)All connexin proteins contain 
four transmembrane domains (labeled TM 1-4), two extra cellular loops, and three 
cytoplasmic domains that include the N- and C-termini. The positions of Cx32 
cytoplasmic lysines, which may be subject to acetylation, are indicated.. (B.) Pairs of 
hexameric connexin channels align at cell-cell borders to form pores between 
neighboring cells (depicted in purple).
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Figure 3. Connexins mediate direct cell-cell communication and influence a 
variety of physiological processes. Members of the connexin protein family have 
been implicated in diverse physiological processes such as those depicted above. 
Connexin dependent pathways are regulated either through  GJ mediated 
intercellular communication, the passage of molecules through unpaired 
hemichannels, or through connexin interactions with intracellular proteins that are 









Figure 4. Protein turnover is  regulated by acetylation through competition with ubiquitination
for lysine occupancy(top), alterations of  interaction sites for binding partners that regulate 
turnover (middle) or through interaction with acetyltransferases or deacetylases that have intrinsic 



























Gap junctions are dynamic structures(Lauf, Giepmans et al. 2002; Flores, Nannapaneni et 
al. 2012; Wayakanon, Bhattacharjee et al. 2012), composed of short-lived (Fallon and 
Goodenough 1981; Yancey, Nicholson et al. 1981; Laird 1991 ) connexin proteins. The level of 
GJ-mediated communication between cells is dependent upon the amount of connexin protein 
available for incorporation into hemichannels, as well on efficient assembly and trafficking of 
the hemichannels. Post-translational modifications alter the biochemical properties of many 
proteins and thus fine-tune their involvement in physiological processes. GJ-mediated cell-cell 
communication is an example of a process that is modulated by post-translational modifications. 
For example, connexin phosphorylation has been  implicated  in the regulation of GJ  
gating(Mitra, Xu et al. 2012), assembly(Musil, Cunningham et al. 1990; Musil and Goodenough 
1991; Lampe 1994),  and disassembly(Lau, Kanemitsu et al. 1992; Leithe and Rivedal 
2004).This work highlights to role of another post-translational modification, lysine acetylation, 
as a potential regulator of connexin protein stability and GJ assembly. 
 Reversible, covalent, post-translational modifications serve as regulators of protein 
structure and function. Among these modifications, ubiquitination, neddylation, sumoylation, 
methylation, and acetylation all occur on  lysine residues, which have accessible epsilon-amino 
groups (Yang and Seto 2008). The consequences of lysine modifications vary according to the 
amino acid sequence surrounding the modification site and the charge and size of the modifying 
moiety.  
Ubiquitination entails the enzymatic attachment of a single or polymeric chain of the 76- 
amino acid peptide, ubiquitin, to the substrate protein. This modification promotes protein 
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degradation (reviewed in (Kornitzer and Ciechanover 2000)), regulates endocytosis and protein 
sorting(reviewed in (Haglund and Dikic 2012)), and modulates protein-protein 
interactions(reviewed in(Zhang 2003)). Neddylation and sumoylation refer to the addition of 
small, ubiquitin-like proteins to substrates, which also modulate protein-protein interactions by 
altering secondary and tertiary protein structure (reviewed in (Rabut and Peter 2008),(Geiss-
Friedlander and Melchior 2007)). Methylation and acetylation  involve the addition of small 
functional groups to lysine, again resulting in altered interactions with other proteins that are 
mediated by changes in confirmation and charge of the modified protein (reviewed in (Yang and 
Seto 2008; Zhang, Wen et al. 2012)). These altered protein-protein interactions regulate protein 
stability(Ianari, Gallo et al. 2004; Geng, Liu et al. 2012), enzymatic activity(Vethantham, Rao et 
al. 2008; Lirussi, Antoniali et al. 2012), localization(Ishfaq, Maeta et al. 2012; Kjenseth, Fykerud 
et al. 2012), complex formation(Chan, Krstic-Demonacos et al. 2001; Kovacs, Murphy et al. 
2005; Lee, Lee et al. 2008), and other features of protein function. 
 Many post-translational-modifications of lysine residues were initially identified 
on histones (e.g.: (Gershey, Vidali et al. 1968; Goldknopf, Taylor et al. 1975; Goldknopf and 
Busch 1977)). Histone modifications influence transcriptional regulation by altering the 
electrostatic interactions between histones and DNA, in turn altering transcription factor access 
to the chromatin(reviewed in (Li, Nagaraja et al. 1993)). It eventually became evident that many 
transcription factors undergo post-translational modification of lysines as well, with acetylation 
and ubiquitination being the most common (Kuras, Rouillon et al. 2002; Gay, Calvo et al. 2003; 
Ianari, Gallo et al. 2004; Akiyama, Kamitani et al. 2005).  
Ubiquitination has emerged as an important regulator of degradation of cytoplasmic 
proteins (Jennissen and Laub 1988; Laszlo, Doherty et al. 1990; Watson, Laszlo et al. 1991). 
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Acetylation, however, was initially assumed to be rare among proteins residing outside of the 
nucleus.  Alpha-tubulin was the first cytoplasmic acetylated protein found to be acetylated, in 
1985(L'Hernault and Rosenbaum 1985), followed by the occasional identification of acetylation 
sites on widely studied proteins such as p53(Li, Luo et al. 2002). It was not until proteomic 
technologies improved in the past decade that hundreds of other cytoplasmic and mitochondrial 
acetylated proteins were identified(Kim, Sprung et al. 2006; Choudhary, Kumar et al. 2009). 
Acetylation of cytoplasmic proteins has been implicated in the regulation of a variety of 
processes such as microtubule- mediated regulation of cell motility(Tran, Marmo et al. 2007) and 
chaperone- mediated protein folding(Scroggins, Robzyk et al. 2007). 
Acetylation regulates protein turnover through several distinct mechanisms. In many 
cases there is competition between acetylation and ubiquitination of the same lysine, such that 
acetylation prevents ubiquitin-mediated proteasomal degradation of the protein (Gronroos, 
Hellman et al. 2002; Ito, Kawaguchi et al. 2002; Jin, Jeon et al. 2004; van Loosdregt, Vercoulen 
et al. 2010). Acetylation can also act as a signal that modulates protein-protein interactions in 
ways that  either decrease (Jacob, Lund et al. 2001; Goel and Janknecht 2003; Suryaraja, Anitha 
et al. 2013) or increase (Jiang, Wang et al. 2011) recruitment of degradation machinery.  Here we 
suggest that K231 and K260 of Cx32 are potential acetylation sites and play a role in regulating 
Cx32 turn-over.  Furthermore, we implicate HDAC6 as a regulator of Cx32 acetylation and 
stability, but show that it does not alter Cx43 acetylation. Taken together, these results suggest 
that acetylation is likely to be a post-translational modification  that is common to many 
connexin proteins, but that  the regulation of connexin acetylation varies amongst members of 




Cx43 localization, but not acetylation is altered by loss of HDAC6 activity. 
Our laboratory has used HDAC6 +/+ and -/-  mouse embryonic fibroblasts (MEFs) in 
experiments investigating the role of microtubule acetylation in cell motility and vesicle 
transport((Tran, Marmo et al. 2007) and Salam et al, in prep). Meanwhile HDAC6 has been 
implicated as a major regulator of the acetylation of cytoplasmic proteins, with an expanding list 
of substrates (Hubbert, Guardiola et al. 2002; Kovacs, Murphy et al. 2005; Zhang, Yuan et al. 
2007).  As we worked to develop antibodies against pan-acetyl lysine, we became interested in 
detecting and studying the acetylation of cytoplasmic proteins that are often overlooked in large 
scale proteomic screens due to poor solubility under common lysis conditions. Connexins are 
one such group of proteins, as they require an ionic detergent such as SDS in order to become 
solubilized.  
Since the HDAC6 +/+ and -/- MEFs express a readily detectable level of Connexin43 
(Cx43), we began by assessing the acetylation of Cx43 in these cells. Cell extracts prepared  in 
the presence of phosphatase inhibitors revealed that both phosphorylated (Figure 1A. upper 
band) and non-phosphorylated (Figure 1A., lower band) Cx43 are acetylated under steady state 
conditions in HDAC6 +/+ MEFs. Phosphorylation decreases the electrophoretic mobility of 
Cx43 and is detected on GJ associated Cx43, whereas the unphosphorylated Cx43 band is 
derived from the newly synthesized protein(Musil, Cunningham et al. 1990). This suggests that 
acetylated Cx43 exists in the cytoplasm as well as GJ.  
Since we detected acetylated Cx43 in the cytoplasmic pool, we hypothesized that the 
cytoplasmic deacetylase, HDAC6, could regulate Cx43 acetylation. Acetylation can modulate 
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protein localization (Gay, Calvo et al. 2003; Ishfaq, Maeta et al. 2012), so we hypothesized that 
the localization of Cx43 in HDAC6 -/- or HDAC6 inhibited WT MEFs would differ from control 
WT MEFs. Immunostaining revealed that the localization of Cx43 is dramatically altered when 
HDAC6 activity is lost either through HDAC6 deletion (Figure 1B. HDAC6 -/-) or 
pharmacological inhibition (Figure 1B., HDAC6 +/+, 18h TubA). Loss of HDAC6 activity 
results in increased cytoplasmic and especially perinuclear localization of Cx43.  Based upon 
these results, we hypothesized that Cx43 acetylation was regulated by HDAC6 activity and the 
loss of HDAC6 activity would increase Cx43 acetylation. However, probing Western blots of 
Cx43 IPs with antibodies against pan-acetyl lysine revealed that Cx43 was not hyperacetylated 
when HDAC6 activity was lost (Figure 1C.), suggesting that the altered Cx43 localization that 
we observed was not the result of increased Cx43 acetylation.  
Cx32 is an acetylated protein 
While we were investigating Cx43 acetylation, another group simultaneously published a 
fairly extensive study of Cx43 acetylation (Colussi, Rosati et al. 2011).  At that time, we shifted 
our focus to the acetylation of Cx32.  The Cx43 acetylation sites proposed by Colussi et al. are 
not conserved in Cx32. Comparison of the regulation of the two divergent connexins by the same 
post-translational modification seemed likely to provide valuable information about connexin 
acetylation as a general regulatory mechanism. 
We are the first to report that Cx32 is acetylated (Figure 2A.). We detected both 
acetylation and ubiquitination of total Cx32 immunoprecipitated from N2a cells transfected with 
Cx32 plasmids. These post-translational modifications of Cx32 exist at readily detectable levels 
in cells that have not been treated with drugs or otherwise perturbed. A pilot experiment carried 
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out by Ranju Kumari and Elliot Hertzberg revealed that broad inhibition of Class I and II 
HDACs with TrichostatinA (TSA) resulted in the accumulation of Cx32 protein (Figure 2B.).  
TSA treatment also resulted in increased acetylation of Cx32 (Chapter 3. Figure 1B.) and thus 
we hypothesized that Cx32 acetylation could influence Cx32 stability. Moving forward, we 
began to use HDAC inhibition as a tool to study the physiological role of Cx32 acetylation.  
Acetylation can  regulate protein folding (Costantini, Ko et al. 2007)  and subcellular 
localization(Gay, Calvo et al. 2003; Ishfaq, Maeta et al. 2012) and in doing so, is often restricted 
to a particular pool of a protein of interest. Information about the localization of an acetylated 
protein could reveal details about the particular role of its acetylation. We carried out cell surface 
biotinylation experiments in order to determine if acetylated Cx32 was clearly enriched or 
excluded from the cell surface. 
 Cell surface biotinylation, fractionation based upon solubility in 1% Triton-X (to 
separate Triton-X insoluble GJ from other Cx32 pools),followed by immunoprecipitation of  
Cx32 from plasma membrane (biotinylated) and cytoplasmic(non-biotinylated) fractions was 
carried out in order to determine which subcellular pools contained acetylated Cx32. Probing 
each fraction with antibodies against pan-acetyl-lysine revealed that acetylated Cx32 was present 
in Triton-X soluble and insoluble fractions of both cytoplasmic and plasma membrane associated 
pools (Figure 3A.). Quantification of normalized acetylated Cx32: total Cx32 ratios from three 
independent experiments indicated that acetylated Cx32 was not enriched in any particular 
fraction, but instead was found throughout the cellular Cx32 pool (Figure 3B.). It is worth noting 
that most of the Triton-X insoluble Cx32 that we detected by cell-surface biotinylation is 
unlikely to have been GJ associated because extracellular residues would not have been easily 
accessible to the biotinylation reagent when incorporated in GJ. Instead, the biotinylated, cell-
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surface localized, acetylated Cx32 was likely in hemichannels that may have eventually become 
incorporated into GJ plaques. Our data should be reassessed alongside studies that determine the 
fate of Triton-X insoluble hemichannels, in order to determine if they are likely to become 
incorporated in to GJ.  
Treatment with Brefeldin-A (BFA) results in the accumulation of secretory proteins in 
the endoplasmic reticulum. These include ER-resident proteins and nascent proteins that were in 
the ER and Golgi at the time of treatment (Sciaky, Presley et al. 1997). We treated Cx32 
expressing cells with BFA for 12 hours in order to determine if Cx32 acetylation was dependent 
upon exit from the secretory system, meaning that it was likely to occur at the cell surface. We 
found that Cx32 remained acetylated after BFA treatment (Figure 3C.), suggesting that 
acetylation may occur prior to exit from the secretory system. This is in agreement with the 
results shown in Figure 3A. and 3B., which indicate that acetylated Cx32 is not restricted to the 
plasma membrane. 
HDAC6 activity regulates Cx32 protein level and post-translational modifications 
Cx32 protein accumulated in the perinuclear region when cells were treated with TSA 
overnight (Figure 4A.). HDAC6 inhibition by overnight TubastatinA treatment (+TubA) results 
in a similar Cx32 distribution (Figure 4B.). The subcellular distribution of Cx32 in both cases is 
similar to that of Cx43 when HDAC6 activity is lost (compare Figure 4. to Figure 1B.). 
Inhibition of HDAC6 activity via TubastatinA treatment resulted in decreased ubiquitination of 
Cx32 (Figure 5A.). This was consistent was the accumulation of Cx32 protein that accompanied 
TSA treatment, since HDAC6 is among the large cohort of deacetylases inhibited by TSA 
(Figure 2B.) and TubastatinA treatment (Chapter 3. Figure 1C.).  
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HDAC6 has been co-immunoprecipitated with substrates such as HSP90(Kovacs, 
Murphy et al. 2005), cortactin (Zhang, Yuan et al. 2007), and tubulin(Zhang, Li et al. 2003), thus 
we hypothesized that Cx32 interacts with HDAC6. We probed Cx32 immunoprecipitates from 
lysates that lacked ionic detergent for interactions between Cx32 and HDAC6 (Figure 5B.).  
HDAC6 and Cx32 were expressed in N2a cells from exogenous cDNAs for these experiments. 
We found that HDAC6 and Cx32  co-immunoprecipitate and that their interaction  is 
significantly reduced in the presence of the TubastatinA (Figure 5C.), which has been reported to 
inhibit the C-terminal catalytic site of HDAC6(Haggarty, Koeller et al. 2003).  This TubastatinA 
induced reduction of Cx32-HDAC6 interaction suggests that the interaction occurs through the 
C-terminal catalytic site of HDAC6 and is dependent upon Zn2+ binding to HDAC6 
(TubastatinA chelates the Zn2+). A similar loss of interaction due to TSA exposure, has been 
reported for the association of HDAC6 and HSP90 (Kovacs, Murphy et al. 2005). 
Depletion of HDAC6 through expression of HDAC6 shRNA also resulted in an 
accumulation of Cx32 protein (Figure 6A.). HDAC6 shRNA expression causes a minor 
accumulation of acetylated Cx32 (Figure 6B.), as compared to Pharmacological inhibition of 
HDAC6, which increases Cx32 acetylation level appreciably (Chapter 3. Figure 1E.). However, 
depletion of HDAC6 through shRNA expression (Figure 6C.) resulted in a clear reduction in 
Cx32 ubiquitination.  It is possible that the pharmacological inhibition caused nearly complete 
inhibition of HDAC6, whereas shRNA expression did not reduce HDAC6 expression enough to 
generate a detectable increase in acetylation, given the constraints of available pan-acetyl-lysine 
antibodies. Another possibility is that other HDACs compensate for HDAC6 after prolonged 
reductions in expression (shRNA expression was for 48 hours, compared to12 hour 
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pharmacological inhibition). This could also be happening in the case of Cx43 and the      
HDAC6 -/- MEFs.  
 C-terminal lysines influence Cx32 turnover 
Cx32 has 3 cytoplasmic domains; the N-terminus, cytoplasmic loop, and C-terminus. 
There are 9 lysines located in these domains and several of them were mutated to arginine in 
order to abolish potential cytoplasmic acetylation sites, in order to test the hypothesis that Cx32 
accumulation that accompanied TSA treatment was due to altered Cx32 acetylation. KR 
mutations at K231 and K260 prevented the accumulation of Cx32 in response to TSA treatment 
(Figure 7A.).  We carried out several experiments to determine if K231 and K260 are major 
acetylation sites in Cx32 and to begin to determine the role of Cx32 acetylation. 
Probing Western blots of Cx32 immunoprecipitates with pan-acetyl lysine antibodies 
revealed that Cx32 K231 +260R(2R) was still acetylated (Figure 7B.). Since acetylation and 
ubiquitination often occur on the same lysines, we also probed for ubiquitination and found that 
Cx32 2R was ubiquitinated to roughly WT levels (Figure 7C.). However, the accumulation of 
ubiquitinated Cx32 in response to proteasome inhibition through MG132 treatment was reduced 
in 2R compared to WT (Figure 7C., +MG132). Based upon this result and the earlier observation 
that loss of HDAC activity resulted in Cx32 accumulation, we hypothesized that K231 and K260 
were involved in modulating Cx32 turn-over.  
We carried out 35-S pulse-chase experiments in order to compare the turn-over of 
Cx32WT and 2R (Figure 8A.).  We found that there was significantly more Cx32 2R remaining 
after 1.5 hours chase, as compared to WT, confirming that K231 and/or K260 influence Cx32 
turn-over (Figure 8B.). This increase in Cx32 stability was not accompanied by altered 
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subcellular distribution of Cx32 (Figure 8C., top panels and 8D.). Furthermore, Cx32 2R 
resembled WT after overnight HDAC6 inhibition (Figure 8C., bottom panels). Taken together, 
these results implicated K231 and K260 in the regulation of Cx32 stability, but failed to clarify 
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Figure 1. HDAC6 regulates Cx43 localization independent of acetylation.  
(A.)Cx43 acetylation was detected by immunoprecipitating endogenous Cx43 
from HDAC6 +/+ MEFs  in the presence of phosphatase inhibitors . Western 
blots were probed with antibodies against pan-acetyl  lysine (AcK) and Cx43. 
(B.)Cx43 was detected by immunofluorescence in HDAC6 +/+ MEFs, HDAC6 
-/- MEFs, and HDAC6 +/+ MEFs with HDAC6 inhibited for 18 hours by 
treatment with 20 µM TubastatinA . (C.) Cx43 acetylation in each of these cases 
was assessed by immunoprecipitating Cx43 and then probing Western blots of 
the immunoprecipitates with antibodies against Cx43 and pan-acetyl lysine 
(AcK). 
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Figure 2. Cx32 accumulates in response to HDAC inhibition. (A.)Cx32 
post-trasnslational modifications were detected  by probing Western blots of  
anti-Myc-tag immunoprecipitates of Cx32-Myc/His from N2a cells transfected 
with pcDNA3.1-Cx32-Myc/His with antibodies against pan-acetyl lysine 
(AcK) and pan-ubiquitin (Ub) , as well as Cx32 and Myc-tag as loading 
controls . (B.)N2a cells expressing  WT Cx32 and several KR mutants of 
cytoplasmic residues were treated for 18 hours with DMSO (-) or 1µM TSA 
(+) and Cx32 protein was detected by Western blotting.. This experiment was 
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Figure 3. Acetylated Cx32 is found in the cytoplasm and at the cell 
surface.(A.)N2a cells expressing pIRESegfp-Cx32 were subjected to cell-
surface biotinylation. Biotinylated cell extracts were prepared in a buffer 
containing 1% Triton X-100 (S) and Triton insoluble(I) proteins were 
sedimented and solublized in a buffer containing SDS.  Strepavidin based 
isolation of biotinylated proteins was used to separate cytosolic (C)  and 
plasma membrane (PM) proteins, followed by immunoprecipitation of Cx32 
in order to detect acetylated and total Cx32 by Western blotting.   (B.)Average 
intensities of AcCx32, normalized over total Cx32, are plotted for 3 
independent experiments +/- S.E.M.  Student’s T-test was used for statistical 
analysis, which revealed no significant differences between the amounts of 
AcCx32 found in the different fractions. (C.)N2a cells expressing Cx32-
Myc/His were treated for 12 hours with 5 µg/ml Brefeldin-A (BFA) or DMSO 
vehicle (C). Cx32 mmunoprecipitates were probed for Cx32 and pan-acetyl 
lysine (AcK) content.  
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Figure 4. Cx32 accumulation after TSA and TubastatinA treatment are 
similar. N2a cells were transfected for 56 hours with pcDNA3.1Myc/His-
Cx32, then treated overnight with a broad class I and II HDAC inhibitor, 
TSA (A. +TSA),  or the HDAC6 specific inhibitor, TubastatinA (B. TubA), 
or DMSO (A, B Control).  Cx32 immunostaining was imaged by confocal 
microscopy at 63x magnification and  6x 0.29 µm  slice Z-projections are 
shown here. Scale bars = 25 µm.  
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Figure 5. HDAC6i increases Cx32 acetylation and reduces 
polyubiquitination . (A.)Polyubiquitination of Cx32 after HDAC6i was 
assessed by  transfecting N2a cells with  Cx32-Myc/His and then treating  for 
6 hours with 20 µM TubastatinA (+ TubA) or DMSO(-TubA), then Cx32 was 
immunoprecipitated and Western blots of immunoprecipitates were probed 
with antibodies against Cx32 or  poly-ubiquitin. Note that the amount of Cx32 
in the +TubA sample is clearly increased while poly-ubiquitin is slightly 
decreased as compared to DMSO treated, meaning that overall poly-
ubiquitination was greatly decreased by HDAC6 inhibition. (B.)Cx32 
association with HDAC6 was also assessed by co-immunoprecipitation in the 
presence of DMSO (- TubA) or 20 µM TubastatinA (+TubA) .  N2a cells 
expressing Cx32-Myc/His and HDAC6-FLAG were treated overnight with 
DMSO or TubastatinA 48 hours post-transfection for these experiments. 
Western blots were probed with antibodies against Myc-tag (Cx32), FLAG-tag 
(HDAC6) and beta-tubulin.  (C.)Average ratio of HDAC6:Cx32 in IP is 
plotted +/- S.E.M. and Student’s T-test indicated that there is a significant 
difference between the amount of HDAC6 in +TubA and –TubA Co-Ips (*) 
p<0.05.  
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Figure 6. HDAC6 KD results in Cx32 protein accumulation and reduced 
ubiquitination. (A.)N2a cells were co-transfected with plasmids encoding 
Cx32-Myc/His  and shRNAs against HDAC6 or  a random sequence (Scr). 
Cx32-Myc/His was isolated by Co2+ affinity binding 48 hours post-
transfection and post-translational modifications were assessed by Western 
blotting. Crude extracts were blotted and probed for Cx32, tubulin, and 
acetylated tubulin. Hyperacetylation of  tubulin was used to confirm that 
HDAC6 level had been reduced by shRNA expression because the steady 
state level of HDAC6 expression in N2a cells is difficult to detect. Cx32 
acetylation was detected by probing the blot of affinity isolated Cx32 with 
antibodies against pan-acetyl lysine (AcK, B.) and ubiquitination was 
detected by probing similar blots with antibodies against ubiquitinated lysine 
(Pan-Ub, C.). 
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Figure 7.  Post-translational modifications of  Cx32 cytoplasmic lysines 
are regulated by TSA treatment. (A.)N2a cells expressing  WT Cx32 and 
several KR mutants of cytoplasmic residues were treated for 18 hours with 
DMSO (-) or 1µM TSA (+) and Cx32 protein was detected by Western 
blotting.. Red boxes denote KR mutants that did not accumulate with TSA 
treatment. This experiment was conducted by Ranju Kumari and Elliot 
Hertzberg. (B.)Acetylation and (C.)ubiquitination of  WT  Cx32 and 
K231+260R (2R) Cx32 were detected by probing Western blots of  Cx32 
immunoprecipitates with antibodies against pan-acetyl lysine (AcK) (B.)  and 
pan-ubiquitin (C.) respectively . N2a cells were transfected with Cx32-
Myc/His WT or 2R for 48 hours  in both experiments. Cells were treated with 
DMSO (- MG132) or 10 µM  MG132 (+MG132, proteasome inhibitor) for 6 
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Figure 8.  Continued  
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Figure 8. K231 and K260 modulate Cx32 turn-over, but not localization.. 
(A.) Turn-over of Cx32 WT and K231 +260R (2R) was assessed  by 35-S 
pulse-cahse assay (as described in methods).Immunoprecipitated 35-S Cx32 
was detected by Western blotting and autoradiography. The Western blot was 
exposed directly to a storage phosphor screen overnight and then 
phosphorimaged (representative phosphorimage shown). Then the blot was 
probed with an antibody against Myc-tag and the 35-S signal for each sample 
was normalized over Cx32-Myc load. (B.)Mean normalized 35-S remaining 
after 1.5 hour chase are plotted +/- S.E.M. (n=3) and Student’s t-test was used 
for statistical analysis. (*) p<0.05 as compared to WT. (C.) N2a cells 
expressing WT or 2R Cx32-Myc/His were grown on glass coverslips for 48 
hours and then treated overnight with 20 µM TubastatinA (+TubA) or DMSO 
(-TubA) and fixed. Cx32-Myc/His was detected by immunostaining of Myc-
tag, followed by confocal microscopy at 63x magnification. Images are Z-
projections of 6 slices that were most in focus at points of cell-cell contact. 
(D.) Mean Cx32 staining intensity at cell-cell junctions normalized against 
cytoplasmic Cx32 staining intensity +/-S.E.M.  are plotted for control (-TubA) 




 Here we have shown that Cx32 is an acetylated protein and that Cx32 acetylation is 
regulated by HDAC6. Acetylated Cx32 is found in the cytoplasm and at the cell surface, 
suggesting that acetylation is a common post-translational modification of Cx32. Further, both 
ubiquitination and acetylation can be detected in the same Cx32 immunoprecipitate, without the 
use of pharmacological inhibitors to prevent the reversal of either modification.  
Pharmacological or genetic manipulation of HDAC6 activity resulted in Cx32 protein 
accumulation and decreased ubiquitination, suggesting that acetylation may be a regulator of 
Cx32 stability. Interestingly, pharmacological or genetic inhibition of HDAC6 activity did not 
alter Cx43 acetylation, suggesting that the acetylation of Cx32 and Cx43 are regulated through 
different pathways. 
Despite the fact that Cx43 acetylation did not change due to altered HDAC6 activity, we  
observed a reduction in Cx43 at points of cell-cell contact in HDAC6 -/-  MEFs, as well as in 
HDAC6 +/+ MEFs treated with TubastatinA.   A study by Shaw et al. demonstrated that 
microtubule dependent delivery of Cx43 to cell-cell junctions is important for proper Cx43 GJ 
formation(Shaw, Fay et al. 2007). Recent work in our lab has shown that microtubule based 
intracellular transport becomes less efficient when HDAC6 activity is lost (Salam et al., in prep), 
so perhaps the altered localization of Cx43 that we observed was due to a transport defect that is 
independent of Cx43 acetylation.  
We used HDAC inhibitors as a tool to promote the accumulation of acetylated Cx32 in 
order to study the consequences of Cx32 acetylation. We found that overnight HDAC inhibition 
caused Cx32 protein to accumulate in the perinuclear region of N2a cells. The accumulation of 
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Cx32 protein occurred when HDAC6 was specifically inhibited with TubastatinA or as a result 
of broad class I and II HDAC inhibition with TSA.  Both inhibitors likely altered many aspects 
of overall cellular physiology since they alter the acetylation of numerous substrates.  Later 
experiments were carried out with shorter periods of HDAC inhibition, which stabilized Cx32 
protein but did not result in global protein trafficking defects (see Chapter 3. of this thesis). 
Since we observed an accumulation of Cx32 protein after TSA treatment, we 
hypothesized that acetylation is a regulator of Cx32 stability. Screening a number of cytoplasmic 
KR mutants for the ability to prevent Cx32 protein accumulation in the presence of TSA 
identified K231 and K260 as putative acetylation sites.  The Cx32 K231+K260R (2R) mutant 
turned over more slowly than WT and showed reduced ubiquitination, providing support for the 
hypothesis that acetylation modulates Cx32 stability. However, we found that   2R Cx32 
acetylation was not appreciably reduced when compared to WT.  2R Cx32 also still seemed to 
accumulate after HDAC6 inhibition. Furthermore, we had not screened all 9 of the cytoplasmic 
lysines found in Cx32 and the screen had been carried out with TSA instead TubastatinA.  We 
concluded that K231 and K260 do influence Cx32 stability and are likely acetylation sites, but 









Materials and Methods 
Cell Lines 
WT and HDAC6 null  mouse embryonic fibroblasts were generously provided by Dr. Tso-Pang 
Yao from Duke University. Experiments with transfected cells were carried out in Neuro-2a 
(N2a) cells (ATCC #CCL-131), which lack endogenous connexins. N2a cells are derived from a 
mouse neuroblastoma and can be cultured under conditions that either promote or prevent 
differentiation into a neuronal cell type. All cells were maintained in DMEM supplemented with 
10% FBS at 37°C and 5% CO2, in a humidified environment.  
Plasmids 
Rat Cx32 cDNA in pIRES2eGFP was obtained from Elliot Hertzberg. Rat Cx32 cDNA was 
cloned into BamHI/ApaI sites of pcDNA3.1/Myc-His A. KR and KQ mutations were made 
using Genetailor site directed mutagenesis kit (Invitrogen).  HDAC6-FLAG plasmid was 
generously provided by Dr. Tso-Pang Yao from Duke University. 
Western blotting 
2% SDS and 100mM DTT were added to samples for Western blotting and samples were not 
heated above 25°C.  Proteins were separated on 10% polyacrylamide denaturing gels and 
transferred to nitrocellulose membranes. Blocking and antibody dilution was carried out in PBS 
containing 2% BSA and 0.05% Tween. 
Western blots were probed with mouse anti-Cx32 clone 7c6.6 (Elliot Hertzberg) 1:1000, rabbit 
anti-Cx32 L1 (Elliot Hertzberg) 1:1000, rabbit anti-Myc tag (AbCam) 1:2000, rabbit anti-
acetylated proteins (Cell Signaling Technologies) 1:1000, mouse anti-ubiquitinated proteins 
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clone P4G7 (Covance)1:200, anti-FLAG M2 antibody (Invitrogen) 1:1000, rabbit anti-FLAG 
(AbCam) 1:1000, and mouse anti-beta-tubulin clone 3F3-G2  at 1:2000. 
Anti-Cx32 L1 antibody was used at 1:100 for immunoprecipitation and rabbit anti-Myc-
tag(Abcam) was used at 1:200. 
Western blots were probed with goat anti-rabbit IRdye800 and goat anti-mouse IRdye700 
secondary antibodies (LiCor) and digital images were obtained with the Odyssey imaging system 
(LiCor). 
Drugs and other chemicals 
TubastatinA was obtained from Chemie Tek (catalog # CT-TUBA) and dissolved in DMSO 
prior to further dilution in medium. All chemicals were obtained from Sigma Aldrich, unless 
otherwise indicated.  
Transfections 
An 80-90% confluent 10cm plate of N2a cells was transfected with 12 µg DNA, 24 µl PLUS 
reagent and 36µl Lipofectamine LTX (Invitrogen) according to the manufacturer’s instructions. 
Antibiotic free medium was used for transfections and all subsequent culture steps. Transfection 
mix was removed from cells 4-6 hours post-transfection and cells were subcultured or plated on 
coverslips for microscopy. 
Immunofluorescence  
Cells were grown on acid washed glass coverslips for 48 hour prior to 15 minute, room 
temperature fixation with Histochoice (Sigma Aldrich). Coverslips were washed with PBS prior 
to fixation and all subsequent washes were with PBS supplemented with 0.05% Tween. Blocking 
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and antibody dilutions were carried out in PBS supplemented with 0.05% Tween and 2% BSA. 
Cx32 was detected with rabbit anti-Myc-tag or anti-Cx32 LI diluted 1:500 for 1 hour at room 
temperature.  Alexa-568 goat-anti-mouse secondary antibody(Invitrogen) was used at 1:1000 in 
blocking buffer for 15 minutes at room temperature.  The coverslips were mounted on glass 
slides in Fluoromount (Invitrogen) with 1µg/ml DAPI. 
Imaging 
A  Zeiss LSM 700 confocal microscope system was used to obtain Z-stacks at 63x 
magnification. All images were obtained with a 1 airy unit pinhole.  Laser power, filter settings, 
beam splitter, and scan mode were the same for all images. Brightness and contrast were 
adjusted using ImageJ software, all images were adjusted equally. Cx32 at cell-cell contacts was 
quantified in a single Z-slice where the points of cell-cell contact for a particular cell pair were 
most in focus, as determined by alignment of Cx32 staining and edges of phase image. 
Fluorescence intensity along the contacting edges was quantified by linescan analysis in ImageJ, 
using a 10 pixel, segmented line.  
Cell lysate preparation for IP and Co2+ purification 
Cells were scraped into PBS and collected by centrifugation at 9000 rpm in an Eppendorf 
microcentrifuge. PBS was aspirated and cells were lysed in 470 µl lysis buffer (PBS 
supplemented with 1% Triton-X 100  and protease inhibitors). Then 30 µl 20% SDS was added 
and lysate was mixed well and diluted with 1ml of lysis buffer and passed through a 26.5 gauge 
needle. Debris were removed by centrifugation at 45 krpm at 4 C/15 minutes. 100 µl of 50% 
slurry of Hispur Co2+ coated agarose beads (Pierce) were used to isolate His tagged Cx32, 
which was eluted with lysis buffer containing 300mM imidazole.  
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 35-S Met/Cys Pulse-Chase Assay 
Cells were transfected 48 hours prior to experiments. Each experimental sample consisted of 
confluent 10cm plate of transfected cells.  Cells were rinsed with 3x 4ml PBS and then starved in 
DMEM lacking serum, methionine, and cysteine for 1h.  The 35-S Met/Cys pulse was carried out 
for 20 minutes. Radioactive pulse medium contained 50 mCi/ml of 35-S Met/Cys (Expre35-S35-
S labeling mix, Perkin Elmer) in serum and Met/Cys free DMEM and 4ml/10cm plate was used 
for each sample. After radioactive pulse, each plate was washed with 3x 4ml PBS and complete 
DMEM with an additional 20mM Met/Cys and 10% FBS was added for indicated chase times.   
Cell lysates were prepared as described above and Cx32-Myc/His was isolated with Co2+-
agarose resin.  Co2+ purified Cx32 was analyzed by Western blotting. 35-S labeled Cx32 was 
detected by exposing the blots overnight to a storage phosphor and then imaging with a Storm 
Phosphorimager (GE Life Sciences). Then the blots were probed with antibodies against the Myc 
tag as a loading control.  35-S Cx32 and Cx32-Myc/His bands were quantified using image-J  
and normalized 35-S Cx32 values were obtained for each sample by dividing 35-S Cx32 band 
intensity by Cx32-Myc/His band intensity. 
Cell surface biotinylation 
Biotinylation experiments were carried out 48 hours post-transfection. Confluent 60mm plates of 
transfected cells were used for each experimental sample. Cell surface proteins were labeled with 
2x 2.5 ml of 0.5 mg/ml EZ-Link Sulfo-NHS-SS-Biotin (Thermo Scientific) in PBS supplemented 
with Ca2+ and Mg2+ for 30 minutes, gently shaking in an ice bath. After biotinylation cells were 
rinsed 4x in PBS supplemented with 100mM Glycine and lysed. Biotinylated proteins were 
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isolated by binding to Neutravidin-agarose beads (Thermo Scientific) and then eluted with SDS-
PAGE sample buffer and subjected to Western blotting. Biotinylated Cx32 was detected by 

















































Gap junctions (GJ) have been implicated in diverse physiological processes such as 
embryonic patterning(Warner, Guthrie et al. 1984; Ewart, Cohen et al. 1997; Dobrowolski, 
Hertig et al. 2009; Hatler, Essner et al. 2009; Rhee, Zhao et al. 2009), synaptic 
transmission(Barr, Berger et al. 1968; Brightman and Reese 1969; Alvarez-Maubecin, Garcia-
Hernandez et al. 2000; Houades, Koulakoff et al. 2008), tumor suppression(Mehta, Perez-Stable 
et al. 1999; Edwards, Jondhale et al. 2008), and cardiac conduction (Smith, Green et al. 1991; 
Mureli, Gans et al. 2013), all of which are dependent upon appropriate intercellular 
communication. Despite –or perhaps because of - the broad physiological significance of GJ-
mediated intercellular communication, many questions remain about how it is regulated.  
 GJ-mediated intercellular communication refers to the passage of small molecules 
between the cytoplasm of adjacent cells, allowing cells to coordinate a variety of physiological 
processes such as cell division, migration, and differentiation (reviewed in(Dbouk, Mroue et al. 
2009)). GJ are permeable to a variety of molecules less than 1 kDa in size including metabolites, 
second messengers, and ions. Connexins are the protein subunits that GJ are composed of. There 
are 21 different connexins expressed in mammals and the connexin composition of a particular 
GJ determines its permeability (Willecke, Eiberger et al. 2002; Söhl and Willecke 2004).  There 
is a high level of sequence homology amongst the different connexin gene products, with the 
exception of the cytoplasmic loop and C-terminal domains. The cytoplasmic loops of connexins 
are involved in channel gating and are important determinants of GJ permeability(Wang, Li et al. 
1996). Connexin C-termini vary substantially in length and in their capacity to mediate 
interactions with the cytoskeleton(Giepmans, Verlaan et al. 2001; Chakraborty, Mitra et al. 2010; 
Saidi Brikci-Nigassa, Clement et al. 2012), other junctional complexes(Wei, Francis et al. 2005), 
68
and other cytoplasmic proteins (reviewed in(Dbouk, Mroue et al. 2009)).  The C-terminal 
sequences of connexins  have also been implicated in voltage(Moreno, Chanson et al. 2002),pH 
(Ek-Vitorin, Calero et al. 1996; Francis, Stergiopoulos et al. 1999; Eckert 2002), and chemical 
(Yeager and Nicholson 1996) gating of GJ channels. While C-terminal truncation of connexins 
does not alter single channel conductance, the truncated connexin may accumulate in the 
cytoplasm indirectly reducing overall GJ-mediated cell-cell communication (Barrio, Castro et al. 
1999; Castro, Gomez-Hernandez et al. 1999; Maass, Shibayama et al. 2007; Johnson, Reynhout 
et al. 2012). 
Each GJ is composed of two hexameric connexin hemichannels. The connexin 
hemichannels align within the extracellular space of adjacent cells in order to form a pore 
between the cells(Kumar and Gilula 1996). The aligned hemichannels are located in accretions 
that are referred to as GJ plaques. GJ plaques are dynamic structures that are constantly being 
repopulated at their outer margins, while older hemichannels are removed from the center (Lauf, 
Giepmans et al. 2002; Thomas, Jordan et al. 2005; Flores, Nannapaneni et al. 2012).  The 
balance between hemichannel delivery to and removal from the plasma membrane thus regulates 
the amount of GJ-mediated cell-cell communication and other connexin dependent physiological 
processes occurring within the cell.  
In this study, we focus on the role of C-terminal residues as modulators of Cx32 protein 
level, which as a consequence regulates the amount of Cx32 at the plasma membrane. Most of 
what is known about post-translational modifications of connexins and interactions between 
connexins and cytoplasmic proteins has been deduced by studying Cx43. We chose to focus on 
Cx32 because the variability of C-terminal sequences of connexins raises questions about 
whether or not Cx43 regulation through C-terminal residues and post-translational modifications 
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is conserved among the connexin family as a whole. Further, Cx32 plays an important role in 
neuronal myelination(Scherer, Xu et al. 1998) and can also regulate proliferation(King and 
Lampe 2004; Prost, Bernier-Valentin et al. 2008), so understanding pathways that regulate Cx32 
GJ formation is inherently valuable. Cx32 is the most abundantly expressed connexin in 
Schwann cells and is mutated in the X-linked demyelinating neuropathy, Charcot Marie Tooth 
syndrome (CMTX)(Bergoffen, Scherer et al. 1993). CMTX associated mutations are found 
throughout the Cx32 gene and result in diverse alterations of Cx32 protein, which ultimately 
cause defects in Cx32 trafficking and GJ formation, or GJ gating (Ressot, Gomes et al. 1998; 
Abrams, Freidin et al. 2001; Wang, Chang et al. 2004).  
The quantity of connexin protein available for incorporation into hemichannels and 
eventually into GJ plaques could be regulated through a variety of mechanisms. We report here 
that Cx32 is acetylated and since acetylation is often a regulator of protein stability (reviewed 
in(Caron, Boyault et al. 2005)), we hypothesized that Cx32 acetylation might regulate Cx32 
turnover. Connexins have short half-lives compared to other membrane proteins (Yancey, 
Nicholson et al. 1981; Chu and Doyle 1985; Beardslee, Laing et al. 1998) and recent studies 
have revealed that GJ plaques are highly dynamic(Flores, Nannapaneni et al. 2012; Johnson, 
Reynhout et al. 2012). Further, GJ channels have a low open probability overall, with a small 
fraction actively involved in GJ-mediated cell-cell communication at any instant (Bukauskas, 
Bukauskiene et al. 2001; Curti, Hoge et al. 2012).This suggests that the replenishment of 
hemichannels to GJ plaques must be tightly regulated in order to maintain the proper level of 
coupling between cells. Post-translational modifications such as acetylation may regulate the 
amount of connexin at the cell surface, indirectly regulating GJ-mediated intercellular 
communication as well. Here we identified the C-terminal lysines of Cx32 as likely acetylation 
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sites and showed that altering their charge stabilizes Cx32 protein, increases the amount of Cx32 
localized in the plasma membrane, and results in reduced growth of cell cultures. Additionally, 
we show that C-terminal lysines are dispensable for Cx32 channel function and suggest that 
increasing plasma membrane associated Cx32 regulates proliferation or apoptosis through a 
mechanism that may be independent of GJ mediated communication. 
Results 
HDAC6 inhibition causes Cx32 protein accumulation 
Post-translational acetylation regulates the turnover of many proteins (Li, Luo et al. 2002; 
Ianari, Gallo et al. 2004; Costantini, Ko et al. 2007; Geng, Liu et al. 2012), thus deacetylase 
inhibitors are often employed to promote the accumulation of acetylated proteins. Cx32 protein 
accumulated when cells were treated with a broad spectrum deacetylase inhibitor, TrichostatinA 
(TSA) (Figure1A.)  This accumulation of Cx32 protein was accompanied by an increase in Cx32 
acetylation (Figure 1B.), implying that acetylation could be a regulator of Cx32 turnover. 
 HDAC6 is inhibited by TSA and has several known cytoplasmic substrates (Hubbert, 
Guardiola et al. 2002; Kovacs, Murphy et al. 2005; Zhang, Yuan et al. 2007). Unlike other 
deacetylases inhibited by TrichostatinA,HDAC6 is actively retained in the cytoplasm (Verdel, 
Curtet et al. 2000; Bertos, Gilquin et al. 2004) and HDAC6 inhibition does not alter histone 
acetylation or other modes of transcriptional regulation(Haggarty, Koeller et al. 2003).  We 
hypothesized that HDAC6 inhibition would result in the accumulation of acetylated Cx32 
protein, recapitulating the results of TSA treatment, independent of any transcriptional 
perturbations that may have occurred as a result of broad HDAC inhibition.  
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Cx32 protein accumulated in cells that were treated with the HDAC6 inhibitor, 
TubastatinA (Figure 1C.).  This could have been due to increased Cx32 expression or decreased 
Cx32 turnover. We carried out 35-S pulse-chase experiments to compare the turnover of Cx32 in 
cells that had been treated with DMSO (control) or TubastatinA (TubA). 35-S labeled Cx32 was 
detected by autoradiography and total Cx32 in each sample was determined by Western blotting 
(Figure 1D.). Since the amount of Cx32 increased in the presence of TubastatinA, we normalized 
the 35-S band intensity over total Western blot Cx32 band intensity and then reported the 
percentage of normalized 35-S Cx32 remaining at t=1.5 hours. There was nearly twice as much 
Cx32 protein remaining after a 1.5 hour chase when cells were treated with TubastatinA (Figure 
1E.). This result supports the hypothesis that Cx32 accumulation in response to HDAC6 
inhibition was due to stabilization of Cx32 protein and not an increase in Cx32 expression. Cx32 
immunoprecipitates probed with pan-acetyl-lysine (AcK) antibodies revealed that acetylation 
increased as Cx32 protein accumulated due to HDAC6 inhibition (Figure 1F.).  Again, the total 
amount of Cx32 in the HDAC6 inhibited sample increased, but normalized acetylated Cx32 band 
intensity over total Cx32 band intensity ranged from a 2-9 fold increase over the control in 3 
independent experiments.   
After we had shown that total Cx32 turnover is reduced by HDAC6 inhibition, we 
wondered if we were detecting the stabilization of primarily cell-surface localized Cx32 or if 
HDAC6 was modulating the turnover of Cx32 in multiple subcellular compartments. If Cx32 
acetylation reduced the internalization of the cell-surface Cx32 pool, then it would subsequently 
reduce lysosomal degradation of Cx32 protein. It is also possible that nascent Cx32, which 
would be cytoplasmic compartments, could be stabilized by acetylation through the inhibition of 
its proteasomal degradation. Cell-surface biotinylation experiments were carried out in order to 
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determine if acetylated Cx32 was accumulating preferentially in the cytoplasm or at the cell 
surface. This was assessed by comparing the internalization of cell surface Cx32 in cells that had 
either been treated with TubastatinA or DMSO. 
Cell surface proteins were labeled with biotin after 3 hours of pretreatment with 
TubastatinA or DMSO and then either lysed or incubated in medium that again contained either 
TubastatinA or DMSO for an additional 1.5 hours. Biotinylated and total Cx32 were measured 
by Western blotting and ratios of biotinylated: total Cx32 were determined (Figure 2A.). 
TubastatinA treatment reduced the fraction of biotinylated: total Cx32 in the cell at the initial 
time point of the experiment (Figure 2B., top graph), but we also observed a larger fraction of 
biotinylated Cx32 remaining after the 1.5 hour chase in the presence of TubastatinA (Figure 2B., 
bottom graph). Taken together, these results suggest that Cx32 accumulated in the cytoplasm and 
at the cell surface after HDAC6 inhibition.  Immunofluorescent staining and confocal imaging 
confirmed these results. Cx32 staining in both cytoplasmic and cell surface pools was visibly 
increased after 6 hours of TubastatinA treatment (Figure 2C.). 
C-terminal lysines are implicated in HDAC6 inhibitor response 
We hypothesized that acetylation sites in cytoplasmic domains of Cx32 are the most 
likely to be involved in modulating its turnover, since protein turnover depends upon interactions 
with cytoplasmic proteins. Connexins have three cytoplasmic domains; the N-terminus, 
cytoplasmic loop, and C-terminus. Cx32 has 9 lysines located in these domains, thus we made 
single point mutants of each cytoplasmic lysine and tested them for resistance to the HDAC 
inhibitor induced accumulation that we observed with WT Cx32.   Lysine to arginine mutations 
(KR) result in a non-acetylatable residue, while conserving the positive charge of lysine. 
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TubastatinA treatment resulted in the equivalent accumulation of WT and cytoplasmic loop 
KR mutant Cx32 proteins(Figure 3A.). However, C-terminal KR mutations reduced the 
accumulation of Cx32 protein in response to HDAC6 inhibition, as compared to WT Cx32 
(Figure 3A.,B.). C-terminal lysine to glutamine mutations (KQ), which act as an acetylation 
mimetic, also abrogated the HDAC6 inhibitor response (Figure 3B.).  
Single point mutations of Cx32 C-terminal KR did not result in a detectable reduction 
in Cx32 acetylation (data not shown), so we made constructs with all 5 C-terminal lysines 
mutated to arginine (5R) and glutamine (5Q) and probed immunoprecipitates for acetylation. We 
found that 5R Cx32 was still acetylated, but that this acetylation did not increase in response to 
TubastatinA treatment (Figure 3C.).  This suggests that the observed increase in Cx32 
acetylation and accumulation of Cx32 protein in response to HDAC6 inhibition was dependent 
upon C-terminal lysines.  The acetylation level of 5Q Cx32 was visibly lower than WT, but 
increased in response to HDAC6 inhibition (Figure 3C.).   This suggests that a subset of the C-
terminal lysines could be acetylation sites, but that there may be other secondary acetylation sites 
that are detected after HDAC6 inhibition under these experimental conditions. 
Ubiquitination of 5R Cx32 was reduced when compared to WT (Figure 3D.);thus we 
hypothesized that its turnover would also be reduced compared to WT. 35-S pulse-chase 
experiments indicated that Cx32 5R turns over more slowly than WT (Figure 4.).  Replacement 
of C-terminal lysines with glutamine (5Q), in order to mimic constitutive acetylation, slowed 
down Cx32 turnover to an even greater extent than KR mutation (Figure 4.). Unlike Cx32 5R, 
Cx32 5Q acetylation was visibly decreased when compared to WT (Figure 3C.) and its 
ubiquitination was decreased when compared to both WT and 5R Cx32 (Figure 3D.).Taken 
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together, results recapitulated what we found for WT Cx32 when HDAC6 was inhibited and thus 
provide further support for the hypothesis that acetylation modulates Cx32 protein level. 
C-terminal lysines regulate Cx32 level at the cell surface 
Cell surface biotinylation experiments indicated that C-terminal lysines are dispensable 
for the delivery of Cx32 to the cell surface (Figure 5A.). Confocal imaging of immunostained 
N2a cells expressing WT, 5R, and 5Q Cx32 corroborated these results (Figure 5B. –TubA and 
Figure S1.). Quantification of fluorescence intensity at points of cell-cell contact suggested that 
similar amounts of 5R and WT Cx32 are incorporated into GJ (Figure 5B. –TubA and Figure 
S1.).  However, the fluorescence intensity of 5Q Cx32 was increased at points of cell-cell 
contacts, compared to WT and 5R (Figure 5B. –TubA and Figure S1.). Neither 5R nor 5Q Cx32 
protein accumulated at the cell surface in response to 6 hours of TubastatinA treatment, whereas 
WT did (Figure 5B, +TubA and Figure S1.). This confirmed our earlier Western blot results that 
implicated the C-terminal lysines in the HDAC6 inhibitor induced accumulation of Cx32 protein. 
Note that WT Cx32 with HDAC6 inhibition, and the acetylation mimetic mutant, 5Q Cx32, both 
increase the level of Cx32 at the cell surface compared to the WT Cx32 control. This provides 
further evidence that the 5Q mutant phenocopies Cx32 acetylation. 
C-terminal lysines are dispensable for GJ function 
These experiments were carried out by Dr. Charles Abrams at SUNY Downstate. Dual 
whole cell recordings of trans-junctional conductance indicated that 5R and 5Q Cx32 formed 
functional GJ (Figure 6A.). Both of the Cx32 mutants generated trans-junctional voltages that 
were comparable to WT Cx32, indicating that cells expressing all three constructs were well 
coupled. These experiments were conducted with transiently transfected cells that expressed high 
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levels of Cx32 and it is unclear if it would be possible to detect an increase in cell-cell coupling 
above the already high WT level in these experiments.  A three-fold increase in the amount of 
DNA used in transfections did not cause a significant increase in cell-cell coupling for any of the 
constructs, suggesting that the expression of Cx32 in all cases was too high to detect increases in 
coupling (Figure 6B.). 
The voltage gating profile of Cx32 5R resembled WT Cx32, indicating that the mutations 
did not cause any major disruptions in Cx32 protein structure (Figure 6C.).  We are in the 
process of completing the voltage gating experiments for comparison of 5Q and WT Cx32, but 
we anticipate that they will also be similar due to the fact that we have already shown that 5Q 
Cx32 forms functional GJ. 
Acetylation is a modulator of Cx32 mediated suppression of cell culture expansion 
 Cx32 has been shown to act as a tumor suppressor in a variety of cell types, 
particularly when they are poorly differentiated (Mehta, Perez-Stable et al. 1999; Omori, Zaidan 
Dagli et al. 2001; Edwards, Jondhale et al. 2008; Prost, Bernier-Valentin et al. 2008; Jee, Nam et 
al. 2011). Tumor suppression by Cx32 expression could be the result of increased apoptotic cell 
death or decreased cell division. We hypothesized that increasing the cell surface pool of Cx32 
would slow growth either by increasing cell-cell coupling, increasing hemichannel mediated 
paracrine signaling, or through the modulation of interactions between Cx32 and cytoplasmic 
proteins. 
 Equal numbers of N2a cells were transfected with pIRES2egfp, pIRES2egfp-WT, 5R, or 
5Q Cx32 and then were counted 72 hours post-transfection (Figure 6A.). We found that after 72 
hours there were over 50% less 5Q Cx32 expressing cells compared to either pIRES2egfp, 
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pIRES2egfp-WT Cx32, or 5R Cx32 (Figure 6B.).  This could be the result of reduced cell 
division or increased cell death. Since we know that both mutants form functional GJ with WT 
gating properties (Figure 5.), it seems unlikely that this growth suppression is due to toxicity 
associated with overexpression of Cx32. Therefore, we conclude that 5Q Cx32 suppresses the 
growth of N2a cell cultures either through negative regulation of cell cycle progression or 
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Figure 1.HDAC6 inhibition reduces turn-over and increases acetylation of Cx32. (A.)HeLa 
cells expressing pIRES2egfpCx32 were treated overnight with the indicated concentrations of 
TSA and then lysed and subjected to Western blotting . Blots were probed with antibodies 
against Cx32 and beta actin as a loading control. (B.)Acetylation of Cx32 in N2a cells expressing 
pIRES2egfp-Cx32 after overnight treatment with 1 uM TSA was assessed by probing Cx32 
immunoprecipitates with antibodies against pan-acetyl lysine (AcK) (C.).N2a cells were 
transfected with pcDNA3.1Myc/His-Cx32 for 48 hours and then cells were treated for 6 hours 
with the HDAC6 inhibitor, TubastatinA (20 µM) (C.+TubA) or DMSO (C.-TubA). Cx32 and 
beta tubulin were detected by Western blotting. (D.)The turnover of Cx32 with (D.+TubA) and 
without (D.-TubA) HDAC6 inhibition was assessed by 35-S pulse-chase. For pulse chase 
experiments, Cx32-Myc/His transfectants were pretreated  with drug during 1 hour amino acid 
starve and throughout the experiment. Cells were pulsed with 35-S Met/Cys for 30 minutes and 
then either lysed or chased with complete medium with extra Met/Cys. Cx32-Myc/His was 
recovered by Co2+ affinity purification, followed by Western blotting. Western blots were 
exposed directly to a storage phosphor, which was subsequently phosphorimaged. (E.)35-S 
intensity was normalized over total Cx32-Myc load and percent of 35-S Cx32 remaining after 
1.5 hours was quantified from 4 independent experiments and means +/- S.E.M.  are plotted 
here . Student’s T-test was used for statistical analysis. (*) p<0.05 as compared to DMSO 
control . (F.)Cx32 acetylation after overnight HDAC6 inhibition (F.+TubA) or DMSO (F.-
TubA) treatment was assessed by immunoprecipitating Cx32-Myc/His and probing blots of 
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Figure 2. HDAC6 inhibition results in the accumulation of both cytoplasmic and cell 
surface Cx32. (A.)N2a cells were transfected for 48 hours with pcDNA3.1Myc/His-Cx32 and 
then used in cell-surface protein biotinylation experiments. Cells were pretreated for 3 hours with 
either TubastatinA (A.+TubA) or DMSO (A.-TubA) and cell surface proteins were labeled with 
biotin for 30 minutes. After biotinylation cells were either lysed or chased for 1.5 hours with 
complete medium. Biotinylated proteins were isolated by binding to streptavidin and  and 
subjected to Western blotting. Biotinylated Cx32 was detected by probing biotinylated proteins 
with an antibody against Myc-tag. Total Cx32 was also blotted and probed with the Myc-tag 
antibody. (B.) Biotinylated Cx32 as a fraction of total Cx32 for each sample at t=0 is plotted here 
(B. left graph), as well as fraction of biotinylated Cx32 remaining after 1.5 hour chase (B. right 
graph), both +/- S.E.M. Student’s T-test was used to determine statistical significance of 
differences between DMSO and TubastatinA treatments, (*)p<0.05. (C.)Confocal microscopy 
was used to observe the cellular localization of Cx32 after a short (6 hour) TubastatinA 
treatment. Cx32 antibody staining was carried out in N2a cells 48 hours post-transfection with 
pIRES2egfp- WTCx32. Confocal imaging was used to obtain Z-stacks of 0.29µm slices (63X). 
Images shown are maximum intensity projections of 5 slices that were most in focus at points of 
cell-cell contact. Scale bars = 25µm and arrows indicate points of cell-cell contact.  Cells were 
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Figure 3. C-terminal lysines are implicated in HDAC6i response. (A.)Single KR mutations 
were made at each cytoplasmic lysine in pcDNA3.1Myc/His-Cx32. N2a cells were transfected 
with plasmids encoding WTCx32 or one of the 9 cytoplasmic KR mutants for 48 hours, 
followed by overnight treatment with 20 uM TubastatinA (A. +TubA) or DMSO(A. -TubA). 
Cells were then lysed in buffer containing 2% SDS and subjected to Western blotting. Blots were 
probed with antibodies against the Myc-tag to detect Cx32 or beta-tubulin as a loading control. 
(B.).Multi-site mutants were constructed such that all 5 cytoplasmic,C-terminal lysines were 
mutated either to arginine (5R) or glutamine (5Q). N2a cells expressing WT, 5R, or 5Q Cx32 
were treated with 20uM TubastatinA for 6 hours, 48 hours post-transfection. Cx32 and beta-
tubulin were again detected by Western blotting. (C.). Acetylation of WT, 5R, and 5Q Cx32 was 
assessed by immunoprecipitating Cx32 and probing the immunoprecipitates with antibodies 
against Cx32 or pan-acetyl-lysine (AcK).  One of 3 representative experiments is shown. (D.). 
Ubiquitination of WT, 5R, and 5Q Cx32 was assessed by probing Western blots of Co2+ affinity 
purified Cx32 Myc/His with antibodies against pan-ubiquitin and Myc-tag. (E.) Ub-Cx32 
immunoreactivity  was normalized over Cx32-Myc and means of fraction WT Cx32-Ub are 
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Figure 4. C-terminal lysines influence Cx32 turn-over.  (A.)N2a cells were transfected for 48 
hours with pcDNA3.1Myc/His- WTCx32, 5RCx32, or 5QCx32 and then pulsed with 35-S 
Met/Cys for 5 minutes followed by lysis or 1.5 hour chase in complete medium.  Cx32-Myc/His 
was isolated by affinity purification with Co2+ agarose and detected by Western blotting and 
autoradiography. The Western blot was exposed directly to a storage phosphor screen overnight 
and then phosphorimaged (representative phosphorimage shown). Then the blot was probed with 
an antibody against Myc-tag and the 35-S signal for each sample was normalized over Cx32-
Myc load. (B.)Mean normalized 35-S remaining after 1.5 hour chase are plotted +/- S.E.M. (n=3) 
and Student’s t-test was used for statistical analysis. (*) p<0.05 as compared to WT. Note that the 
apparent half-life of Cx32 in these experiments is lower than reported by other groups  and our 
experiment in Figure 1. because the 35-S labeling was carried out for a shorter time (10 minutes 
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Figure 5. C-terminal lysines influence Cx32 localization and HDACi response.  (A.) Cell 
surface biotinylation was performed in order to confirm the presence of WT, 5R, and 5Q Cx32 at 
the cell surface. N2a cells were biotinylated 48 hours after transfection with pcDNA3.1Myc/His- 
WT, 5R, or 5Q Cx32. Biotinylated proteins were isolated by binding to streptavidin and then 
detected by Western blotting. Biotinylated and total  Cx32 were detected by probing Western 
blots with an antibody against the Myc-tag. (B. and C.)The amount of Cx32 at points of cell-cell 
contact was measured by quantifying the fluorescence intensity of Cx32 antibody staining of 
N2a cells 48 hours after transfection with pIRES2egfp- WTCx32, 5RCx32, or 5QCx32 
(B.)Confocal imaging was used to obtain Z-stacks of 0.29um slices (63X). Images shown are 
maximum intensity projections of 6 slices that were most in focus at points of cell-cell contact.  
Cells were incubated with either DMSO (-TubA) or 20µM TubastatinA  (+TubA) for 6 hours 
prior to fixation. Scale bars are 25µm and arrows indicate points of cell-cell contact.(C.) Anti- 
Cx32 fluorescence intensity at points of cell-cell contact was measured as described in methods. 
Average fluorescence intensities at cell-cell contacts for  each set of images is plotted here +/- 
S.E.M. (n=15-23 cell pairs for each group. Student’s T-test was used for statistical analysis of 
means as compared to WT  and * p<0.05   
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Figure 6. C-terminal lysine mutants form functional GJ. (A.) To evaluate the channel 
forming ability of the 5R and 5Q mutants, we measured electrical coupling between cell pairs 
with dual whole-cell recordings. Mean junctional conductance (Gj) for  empty pIRESegfp (I), 
WT, 5R, and 5Q Cx32 are plotted +/- S.E.M. (B.)Cells in experiments plotted here were 
transfected with 3-fold more DNA than in A. (C.). Representative Average normalized Gj-Vj 
relations for 5R and WT Cx32 channels are shown in. Both cells of a pair were voltage clamped 
at the same voltage, then cell 1 (was stepped in 20 mV increments from Vj= –100 to Vj =+100 
mV, and junctional currents (Ij) were recorded from cell 2. The average normalized instantaneous 
(open triangles) and steady-state (filled squares) junctional conductance (Gj) at each Vj were 
calculated from current traces and fit as described in the Methods. Solid lines represent fits to 
Cx325R; broken lines represent fits to data for Cx32WT homotypic and Cx32WT/Cx30WT cell-
cell channels. Representative Average normalized Gj-Vj relations for 5R Cx32 channels . Both 
cells of a pair were voltage clamped at the same voltage, then cell 1 (was stepped in 20 mV 
increments from Vj= –100 to Vj =+100 mV, and junctional currents (Ij) were recorded from cell 
2. The average normalized instantaneous (open triangles) and steady-state (filled squares) 
junctional conductance (Gj) at each Vj were calculated from current traces and fit as described in 
the Methods. Solid lines represent fits to Cx325R; broken lines represent fits to data for Cx32WT 





































Figure 7. Cx32 5Q suppresses growth of N2a cells. (A.)Equal numbers of N2a cells were 
transfected with pIRES2egfp, pIRES2egfp- WT Cx32, 5RCx32, or 5QCx32 and plated on glass 
coverslips after 6 hours. Cells were allowed to grow for 72 hours, then were fixed and mounted 
for imaging. (B.)Cells were imaged at 40x and nuclei were counted from 36 independent fields 
per transfection (n=3).  Mean cell counts for 3 independent transfections were plotted with error 
bars +/- S.E.M.Student’s T-test  was used to compare cell counts at 72 hours post-transfection. 





Figure  S1. Continued
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Figure  S1. Continued
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Figure S1. C-terminal lysines influence Cx32 localization and HDACi response. The amount 
of Cx32 at points of cell-cell contact was measured by quantifying the fluorescence intensity of 
Cx32 antibody staining of N2a cells 48 hours after transfection with pIRES2egfp- WTCx32, 
5RCx32, or 5QCx32 .Confocal imaging was used to obtain Z-stacks of 0.29um slices (63X). 
Cells were incubated with either DMSO (-TubA) or 20µM TubastatinA  (+TubA) for 6 hours 
prior to fixation. Scale bars are 10µm and arrows indicate points of cell-cell contact where Cx32 
staining is in focus within a single Z-slice. Images shown here are representative of those 




The data presented here address the role of C-terminal lysines and their post-translational 
modifications as regulators of Cx32 function. Our results demonstrate that C-terminal lysines 
modulate the turnover of Cx32 protein.  Further, our data suggest that at least a subset of these 
lysines is subject to acetylation. Decreasing Cx32 turnover through KQ mutations or treatment 
with a deacetylase inhibitor resulted in an increase in Cx32 protein at the cell surface. Since 5Q 
Cx32 forms functional GJ channels, we propose a model where acetylation results in increased 
Cx32 channel activity, either as hemichannels or GJ, due to the stabilization of Cx32 protein. 
Also, 5Q Cx32 may participate in increased or new protein-protein interactions with plasma 
membrane or cytoplasmic proteins as a result of its increased plasma membrane localization. 
These protein-protein interactions and/or increased GJ or hemichannel function may contribute 
to the suppression of growth of cell cultures that express 5Q Cx32 by inhibiting proliferation or 
promoting cell death. Thus our data suggest that acetylation may act as a regulator of a variety of 
Cx32 dependent processes that are fine-tuned through alterations in Cx32 protein level. 
We utilized deacetylase inhibitors to promote the accumulation of acetylated Cx32 and 
determined that HDAC6 in particular is a regulator of Cx32 acetylation. While we did not show 
direct interaction through in vitro deacetylation assay, we did show that even brief HDAC6 
inhibition was sufficient to accumulate Cx32 protein throughout the cell and that this 
accumulation was accompanied by increased Cx32 acetylation. These results recapitulated our 
initial results with the broad type I and II deacetylase inhibitor, TSA. It is worth noting that 
HDAC3 and 4 have been implicated as regulators of Cx43 acetylation, which are frequently 
localized at the plasma membrane(Colussi, Rosati et al. 2011). We have not ruled out that 
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possibility that they also deacetylate Cx32. Future experiments should address whether other 
class I and II deacetylases also alter Cx32 acetylation in a way that impacts its stability. 
Our analysis of cytoplasmic lysine mutants of Cx32 revealed that C-terminal lysines are 
involved in the Cx32 accumulation which results from HDAC6 inhibition. To our knowledge, 
other studies have not shown a role for these residues in the regulation of Cx32 turnover or GJ 
plaque dynamics. Other studies have shown that while Cx32 with a truncation of its C-terminal 
domain retains the capacity to form functional GJ, the resultant level of cell-cell coupling is 
inversely proportional to the number of amino acids that were truncated (Barrio, Castro et al. 
1999; Castro, Gomez-Hernandez et al. 1999). Furthermore, much of the truncated Cx32 
accumulates in the cytoplasm, implicating the C-terminus in the regulation of GJ assembly 
and/or disassembly(Ahmad, Martin et al. 2001). Our results provide further support for a model 
of GJ assembly that is regulated by the C-termini of connexins. Specifically, our data suggest 
that post-translational modifications of C-terminal lysines are implicated in the modulation of the 
amount of Cx32 that exists at the cell surface. This cell surface pool of Cx32 may be 
incorporated into GJ or may exist as hemichannels, either of which could regulate downstream 
physiological processes.  
Interestingly, both of our 5 lysine mutants remained detectably acetylated. 5R Cx32 
acetylation was roughly equivalent to WT, but did not increase in response to HDAC6 inhibition. 
This suggests that the 5 C-terminal lysines are indeed acetylated in response to HDAC6 
inhibition, but that there are other acetylated lysines in Cx32. Other physiologically relevant 
Cx32 acetylation may increase when the C-terminal lysines are no longer available because the 
protein may be recognized as unacetylated, resulting in acetylase recruitment. Another 
possibility is that other lysines are spuriously acetylated when normal sites are unavailable, but 
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the protein is not detectably acetylated. 5Q Cx32 acetylation is visibly decreased as compared to 
5R and WT, suggesting that the mutations are actually eliminating acetylation sites. The 
acetylation level of 5Q Cx32 increases after HDAC6 inhibition, but the protein does not 
accumulate, again suggesting enhancement of spurious acetylation in a region of the protein that 
is not involved in regulating Cx32 stability.  
This work also provides evidence that acetylation alters Cx32 protein level through 
protein-protein interactions that are dependent upon the lysines that we mutated and not simply 
through elimination of ubiquitination sites. We come to this conclusion because 5Q Cx32 is 
increased at the cell surface compared to WT and 5R Cx32. Also, 5Q Cx32 suppresses the 
growth of N2a cell cultures, whereas 5R Cx32 does not. Both mutants are more stable than WT 
and show reduced ubiquitination, but these changes are not sufficient to alter the physiological 
consequences of Cx32 expression. The alterations in Cx32 stability that we observed may be due 
to altered protein-protein interactions that are modulated by the loss of positively charged 
residues, which normally occurs as a result of acetylation and is mimicked by KQ mutation. 
Connexins are paradigmatic of a large cohort of proteins that are regulated by interactions 
with binding partners, which cause a particular sequence to change from an intrinsically 
disordered state into a functional secondary structure (Receveur-Brechot, Bourhis et al. 2006; 
Stauch, Kieken et al. 2012).  For example, calmodulin (CaM) is thought to stabilize the 
otherwise disordered structure of the Cx32 C-terminus into an alpha-helix when bound (Stauch, 
Kieken et al. 2012). Chemical gating of Cx32 GJ occurs in the presence of high concentrations of 
Ca2+,  which results in the  loss of CaM binding and the return to a disordered C-terminal 
state(Dodd, Peracchia et al. 2008) (Hertzberg and Van Eldik 1987). Inhibition of CaM binding or 
truncation of CaM binding sites resulted in cytoplasmic accumulation of Cx32, further 
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highlighting the regulatory role of interactions between Cx32 C-terminus and binding 
partners(Ahmad, Martin et al. 2001). Based on this example, we hypothesize that either the 
positive charge of the lysine or the presence or absence of an acetyl group may modulate 
interactions between the C-terminus of Cx32 and its binding partners. This could result in 
alterations of Cx32 structure which in turn modulate Cx32 stability and dynamics at the cell 
surface. Future studies comparing the binding partners of WT and 5Q Cx32 will be necessary in 
order to test this possibility. 
While we are just beginning to understand the role of acetylation as a direct regulator of 
connexins, some earlier studies addressed the overall impact of deacetylase inhibitors on Cx32 
and Cx43 GJ formation.  TSA treatment enhanced GJ-mediated cell-cell communication and the 
amount of Cx32 in GJ  in primary cultures of hepatocytes(Vinken, Henkens et al. 2006). These 
changes occurred independent of increased Cx32 transcription. Interestingly, Cx43 protein level 
increased after TSA treatment as well, but was localized to the nucleus with very little GJ 
formation. These results were recapitulated when primary cultures of mitogen stimulated 
hepatocytes were grown in the presence of 4-Me2N-BAVAH, a structural analog of TSA with 
increased metabolic stability(Vinken, Henkens et al. 2007; Henkens, Vinken et al. 2008).Culture 
in the presence of Me2N-BAVAH promoted hepatocyte differentiation, increased Cx32 GJ 
formation and decreased Cx43 protein level, while having no effect on Cx32 or Cx43 
transcription. These studies did not address whether connexin acetylation was altered by 
deacetylase inhibition, but they provided evidence that deacetylase inhibition could influence GJ 
in varied ways, depending on their constituent connexins. 
A recent report suggested that Cx43 acetylation acts as a negative regulator of GJ 
formation (Colussi, Rosati et al. 2011).  HDAC inhibition was associated with increased 
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acetylation and decreased Cx43 at cell-cell junctions. KQ mutations of putative acetylation 
sites also decreased the amount of Cx43 in GJs.  It is important to note that the Cx43 acetylation 
sites identified in this study (K9, K234, and K264) do not share sequence homology with Cx32.  
Alignment of Cx32 and Cx43 C-terminal amino acid sequences using  protein-protein BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) indicated that there is only one C-terminal lysine in a 
well conserved portion of the two proteins.  It is K250 (NKLLSEQD) in Cx32 and K303 
(NKQASEQN). Our work suggests that K250 of Cx32 could be an acetylation site. The possible 
acetylation of Cx43 K303 and its role as a regulator of Cx43 stability were not addressed in the 
initial characterization of Cx43 acetylation. More work is needed in order to determine if there 
are residues in Cx43, such as K303, which may be involved in regulating GJ-mediated cell-cell 
coupling in a manner that is homologous to C-terminal lysines in Cx32, or if the consequences of 






Materials and Methods 
Cell Lines 
Experiments were carried out in Neuro-2a (N2a) cells (ATCC #CCL-131), which lack 
endogenous connexins. N2a cells are derived from a mouse neuroblastoma and can be cultured 
under conditions that either promote or prevent differentiation into a neuronal cell type. Cells 
were maintained in DMEM supplemented with 10% FBS at 37°C and 5% CO2, in a humidified 
environment. These culture conditions prevent differentiation. N2a cells are particularly well 
suited for studying GJs because they amenable to electrophysiology and biochemical studies 
owing to their high transfection efficiency and small size. 
Plasmids 
Rat Cx32 cDNA in pIRES2eGFP was obtained from Elliot Hertzberg. Rat Cx32 cDNA was 
cloned into BamHI/ApaI sites of pcDNA3.1/Myc-His A. KR and KQ mutations were made 
using Genetailor site directed mutagenesis kit (Invitrogen).  
Western blotting 
2% SDS and 100mM DTT were added to samples for Western blotting and samples were not 
heated above 25°C.  Proteins were separated on 10% polyacrylamide denaturing gels and 
transferred to nitrocellulose membranes. Blocking and antibody dilution was carried out in PBS 
containing 2% BSA and 0.05% Tween. 
Western blots were probed with mouse anti-Cx32 clone 7c6.6 (Elliot Hertzberg) 1:1000, rabbit 
anti-Myc tag (AbCam) 1:2000, rabbit anti-acetylated proteins (Cell Signaling Technologies) 
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1:1000, mouse anti-ubiquitinated proteins clone P4G7 (Covance)1:200, and mouse anti-beta-
tubulin clone 3F3-G2  at 1:2000. 
Anti-Cx32 clone 7c6.6 (Elliot Hertzberg) was used for immunoprecipitation at 1:100. 
Western blots were probed with goat anti-rabbit IRdye800 and goat anti-mouse IRdye700 
secondary antibodies (LiCor) and digital images were obtained with the Odyssey imaging system 
(LiCor). 
Drugs and other chemicals 
TubastatinA was obtained from Chemie Tek (catalog # CT-TUBA) and dissolved in DMSO 
prior to further dilution in medium. All chemicals were obtained from Sigma Aldrich, unless 
otherwise indicated. 
Transfections 
An 80-90% confluent 10cm plate of N2a cells was transfected with 12 µg DNA, 24 µl PLUS 
reagent and 36µl Lipofectamine LTX (Invitrogen) according to the manufacturer’s instructions. 
Antibiotic free medium was used for transfections and all subsequent culture steps. Transfection 
mix was removed from cells 4-6 hours post-transfection and cells were subcultured or plated on 
coverslips for microscopy. 
Immunofluorescence  
Cells were grown on acid washed glass coverslips for 48 hour prior to 15 minute, room 
temperature fixation with Histochoice (Sigma Aldrich). Coverslips were washed with PBS prior 
to fixation and all subsequent washes were with PBS supplemented with 0.05% Tween. Blocking 
and antibody dilutions were carried out in PBS supplemented with 0.05% Tween and 2% BSA. 
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Cx32 was detected with mouse anti-Cx32 clone 7C6.6 (developed by Elliot Hertzberg) diluted 
1:1000 for 1 hour at room temperature.  Alexa-568 goat-anti-mouse secondary 
antibody(Invitrogen) was used at 1:1000 in blocking buffer for 15 minutes at room temperature.  
The coverslips were mounted on glass slides in Fluoromount (Invitrogen) with 1µg/ml DAPI. 
Imaging 
A  Zeiss LSM 700 confocal microscope system was used to obtain Z-stacks at 63x 
magnification. All images were obtained with a 1 airy unit pinhole.  Laser power, filter settings, 
beam splitter, and scan mode were the same for all images. Brightness and contrast were 
adjusted using ImageJ software, all images were adjusted equally. Cx32 at cell-cell contacts was 
quantified in a single Z-slice where the points of cell-cell contact for a particular cell pair were 
most in focus, as determined by alignment of Cx32 staining and edges of phase image. 
Fluorescence intensity along the contacting edges was quantified by linescan analysis in ImageJ, 
using a 10 pixel, segmented line.  
Images were acquired at 40x magnification for cell counting experiments. These images 
consisted of 4x3 image tile scans in a single Z-slice for cell counting experiments. Equal 
numbers of N2a cells were transfected with pIRES2egfp, pIRES2egfp-WT, 5R, or 5Q Cx32 and 
then replated on glass coverslips and allowed to grow for 72 hours. After 72 hours the cells were 
fixed and nuclei were stained with DAPI.  Cells were imaged in 27 independent fields per 





Cell lysate preparation for IP and Co2+ purification 
Cells were scraped into PBS and collected by centrifugation at 9000 rpm in an Eppendorf 
microcentrifuge. PBS was aspirated and cells were lysed in 470 µl lysis buffer (PBS 
supplemented with 1% Triton-X 100  and protease inhibitors). Then 30 µl 20% SDS was added 
and lysate was mixed well and diluted with 1ml of lysis buffer and passed through a 26.5 gauge 
needle. Debris were removed by centrifugation at 45 krpm at 4 C/15 minutes. 100 µl of 50% 
slurry of Hispur Co2+ coated agarose beads (Pierce) were used to isolate His tagged Cx32, 
which was eluted with lysis buffer containing 300mM imidazole.  
 
35-S Met/Cys Pulse-Chase Assay 
Cells were transfected 48 hours prior to experiments. Each experimental sample consisted of 
confluent 10cm plate of transfected cells.  Cells were rinsed with 3x 4ml PBS and then starved in 
DMEM lacking serum, methionine, and cysteine for 1h.  The 35-S Met/Cys pulse was carried out 
for 20 minutes (+/-TubA experiments) or 5 minutes (WT versus 5R/5Q) . Radioactive pulse 
medium contained 50 mCi/ml of 35-S Met/Cys (Expre35-S35-S labeling mix, Perkin Elmer) in 
serum and Met/Cys free DMEM and 4ml/10cm plate was used for each sample. After radioactive 
pulse, each plate was washed with 3x 4ml PBS and complete DMEM with an additional 20mM 
Met/Cys and 10% FBS was added for indicated chase times.   
Cell lysates were prepared as described above and Cx32-Myc/His was isolated with Co2+-
agarose resin.  Co2+ purified Cx32 was analyzed by Western blotting. 35-S labeled Cx32 was 
detected by exposing the blots overnight to a storage phosphor and then imaging with a Storm 
Phosphorimager (GE Life Sciences). Then the blots were probed with antibodies against the Myc 
108
tag as a loading control.  35-S Cx32 and Cx32-Myc/His bands were quantified using image-J  
and normalized 35-S Cx32 values were obtained for each sample by dividing 35-S Cx32 band 
intensity by Cx32-Myc/His band intensity. 
Cell surface biotinylation 
Biotinylation experiments were carried out 48 hours post-transfection. Confluent 60mm plates of 
transfected cells were used for each experimental sample. Cell surface proteins were labeled with 
2x 2.5 ml of 0.5 mg/ml EZ-Link Sulfo-NHS-SS-Biotin (Thermo Scientific) in PBS supplemented 
with Ca2+ and Mg2+ for 30 minutes, gently shaking in an ice bath. After biotinylation cells were 
rinsed 4x in PBS supplemented with 100mM Glycine and either lysed or chased for 1.5 hours 
with complete medium. Biotinylated proteins were isolated by binding to Neutravidin-agarose 
beads (Thermo Scientific) and then eluted with SDS-PAGE sample buffer and subjected to 
Western blotting. Biotinylated Cx32 was detected by probing biotinylated proteins with an 
antibody against Myc-tag. 
Electrophysiology 
Conductance measurements were made by pulsing from Vj=0 to +/- 40 mV. Cytoplasmic bridges 
were excluded by demonstrating the sensitivity of Gj to application of bath solution containing 
octanol. Values for different pairing configurations were compared using the Kruskal-Wallis test 
with Dunn’s multiple comparison test. For determination of steady-state junctional conductance-
junctional voltage (Gj-Vj) relations, cells were held between each pulse at Vj=0 for 22.5 
seconds, and cell 1 was pulsed in 20 mV increments from –100 to +100 mV for 12.5 seconds.  
Any resulting change in current in cell 2, the apposed cell, is attributable to junctional current.  
Currents are displayed with positive up for both cells; thus a positive Vj step in cell 1 causes a 
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downward deflection in cell 2.  For WT and mutants with measurable conductance at Vj=0 mV, 
voltage pulses were preceded by a short (~200 mS) pulse to -20 mV for normalization.  Data 
were collected as described.  Steady-state (t=∞) conductances were determined by fitting each 
current trace to a sum of exponentials. Dividing the current at t=∞ by the applied voltage gives 
the steady-state junctional conductance. For determination of Boltzmann parameters, steady-state 
plots were fit to the product of two Boltzmann distributions of the form:  
Gss(V)=  
{Gmin (+) + (Gmax(+) -Gmin(+))/(1+e[A(+) (V-Vo(+))])}*{Gmin(-) + (Gmax(-)-Gmin(-
))/(1+e[A(-) (V-Vo(-))])} 
where Gss is the steady-state junctional  conductance normalized to Vj=0,  Gmax  is the maximal 
normalized conductance, and Gmin is the normalized residual conductance, which in 
macroscopic recordings is approached as the absolute value of Vj is increased,   V0 is the voltage 
at which the conductance is 1/2 of the difference between Gmin and Gmax and roughly 
corresponds to the voltage at which a single connexin hemichannel has an open probability of 
50%, and A is a parameter which reflects the slope of the Gj-Vj plot and is a measure of voltage 
sensitivity.  A= nq/kT where n is the effective gating charge and q, k and T have their usual 
meanings. The (+) and (-) designations indicate that the parameters are fits to the positive or 
negative limbs of the Gj-Vj relation. The model makes two assumptions that may not always be 
met for connexin gating: 1. It assumes a two state gating process where the energy difference 
between the states is proportional to the applied voltage, and 2: The steady state Gj-Vj arises 
from the gating of two independent apposed hemichannels.  However, the parameters generated 
provide a useful basis for comparison among channels produced by various pairing 
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configurations of mutant and WT connexins.   Homotypic pairs of Cx32WT-IRES-EGFP served 
as a positive control and pairs of empty vector expressing cells served as negative controls for 
homotypically paired mutants. For heterotypic cell pair controls, an additional “heterotypic” 
pairing of Cx32WT-IRES-EGFP with Cx32WT-IRES-DSRed expressing cells was performed. 
Pipette solution: 145 mM CsCl, 5 mM EGTA, 1.4 mM CaCl2, 5.0 mM HEPES pH 7.2; Bath 
solution: 150 mM NaCl, 4 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 5 mM Dextrose, 2 mM 


































Summary of Conclusions 
Based upon the data presented in this thesis we conclude the following; 
 Cx32 undergoes lysine acetylation. 
 
 Acetylated Cx32 is found in both cytoplasmic and cell-surface associated Cx32 pools. 
 
 Cx32 acetylation is regulated by HDAC6 and  thus HDAC6 inhibition results in: 
-Increased Cx32 acetylation 
-Decreased Cx32 ubiquitination 
-Reduced Cx32 turnover 
-Increased Cx32 at the cell surface 
 
 C-terminal lysines modulate Cx32 turnover and are likely acetylation sites. 
 
 KR mutations of C-terminal lysines result in : 
-Decreased Cx32 ubiquitination 
-Reduced Cx32 turnover 
-Cell surface Cx32 protein level resembling WT 
-Cell-cell coupling comparable to WT 
-Growth of mutant expressing culture is comparable to WT 
 
 KQ mutations of C-terminal lysines result in : 
-Decreased Cx32 ubiquitination 
-Reduced Cx32 turnover 
-Increased cell surface Cx32 protein compared to WT  
-Cell-cell coupling comparable to WT 
-Growth of mutant expressing culture is reduced compared to WT 
 
 Based upon comparison of C-terminal KR and KQ mutants to WT Cx32, we 
conclude that acetylation enhances Cx32 protein stability through the modulation of 
protein-protein interactions rather than simple competition for lysine occupancy. KR 
and KQ mutations have different consequences; expression of 5Q Cx32 results in 
increased plasma membrane localized Cx32 and reduces the expansion of the transfected 







Acetylation modulates Cx32 turnover and Cx32 mediated suppression of cell culture expansion 
Here we investigated the role of acetylation as a regulator of Cx32 mediated cell-cell 
communication. Post-translational modifications such as phosphorylation(Laird 2005), 
ubiquitination(Laing and Beyer 1995), acetylation(Colussi, Rosati et al. 2011), and 
sumoylation(Kjenseth, Fykerud et al. 2012) have been  identified as regulators of various aspects 
of Cx43 mediated cell-cell communication. Little is known about post-translational 
modifications of other connexins, such as Cx32. To our knowledge, we are the first to report that 
Cx32 undergoes lysine acetylation.   
Analysis of putative acetylation sites indicated that C-terminal lysines are involved in the 
modulation of Cx32 protein level and are likely acetylation sites. Mutations that mimic 
constitutive acetylation of C-terminal lysines (5Q) reduced Cx32 turnover and increased the 
amount of Cx32 found at the cell surface. The GJ formed by 5Q Cx32 were functional and the 
extent of coupling between cells expressing 5Q Cx32 was the same as WT. Mutations that 
removed putative acetylation sites, but did not mimic acetylation (5R), also reduced Cx32 
turnover. The amount of 5R Cx32 at the cell surface was similar to WT, as were GJ gating and 
the level of coupling between 5R expressing cells, suggesting that acetylation is not required for 
normal GJ function. Interestingly, expression of 5Q Cx32, but not 5R or WT Cx32, resulted in 
reduced expansion of cell cultures compared to cells expressing the empty vector. This result 
suggests that acetylated Cx32 plays a role in the regulation of cell division or cell death. 
We have shown that HDAC6 is a regulator of Cx32 acetylation, which influences Cx32 
protein stability When we found that the effect of HDAC6 inhibition on Cx32 was similar to 
broad HDAC inhibition, we focused our efforts on understanding the HDAC6 mediated 
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regulation of Cx32 because HDAC6 is most abundant cytoplasmic HDAC and we had evidence 
that Cx32 acetylation occurs on cytoplasmic residues (Bertos, Gilquin et al. 2004).  Our cell-
surface biotinylation experiments indicated that acetylated Cx32 is present in the cytoplasm and 
at the cell surface and that HDAC6 inhibition causes Cx32 protein to accumulate in both pools. 
This was result was corroborated by confocal imaging of WT Cx32 in HDAC6 inhibitor treated 
cells, where the intensity of Cx32 staining increased in the cytoplasm and at the cell surface, 
compared to vehicle treated WT Cx32.  The stabilization of Cx32 that occurred as a result of 
HDAC6 inhibition and increased Cx32 acetylation was recapitulated by KQ mutation of likely 
acetylation sites, suggesting that the observed Cx32 stabilization was a direct result of the 
alteration of biochemical properties of the Cx32 C-terminus. 
The consequences of Cx32 acetylation differ from those of Cx43 acetylation 
Acetylation was recently reported to influence the amount of Cx43 in GJs (Colussi, 
Rosati et al. 2011). Global acetylation was assessed in a mouse model for Duchenne’s cardiac 
myopathy (Mdx), where many proteins including Cx43, were found to be hyperacetylated. The 
hyperacetylated Cx43 in Mdx cardiomyocytes displayed a reduced junctional localization 
compared to WT tissue. Further evidence that acetylation regulates junctional Cx43 levels was 
ascertained by manipulating Cx43 acetylation in cultured fibroblasts. Broad spectrum and Class 
IIa specific HDAC inhibitor treatment increased Cx43 acetylation and reduced GJ associated 
Cx43 in the fibroblasts. This result was recapitulated by mutating putative acetylation sites from 
lysine to glutamine in order to mimic constitutive acetylation, such that the localization of KQ 
Cx43 at cell-cell junctions was reduced compared to WT Cx43.  
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Two other studies tested the effects of prolonged culture in the presence of broad 
spectrum HDAC inhibitors on GJ formation and found that while Cx43 accumulated in the 
cytoplasm, HDAC inhibition actually increased the amount of Cx32 in GJs(Vinken, Henkens et 
al. 2006; Henkens, Vinken et al. 2008). These changes were independent of alterations of 
transcription of either connexin gene, but were accompanied by an increase in Cx32 and Cx43 
protein levels. Neither of these studies addressed whether the connexins were acetylated and if 
their acetylation levels were changing as a result of the drug treatments.  
We found that HDAC6 inhibition increased Cx32 acetylation and the amount of Cx32 at 
the cell surface. Mutation of C-terminal lysines to glutamine recapitulated the increase in Cx32 
at the cell surface and also suppressed the expansion of N2a cell cultures, compared to cells 
expressing WT Cx32. It is worth noting that we showed that HDAC6 does not seem to regulate 
Cx43 acetylation, despite a cytoplasmic accumulation of Cx43 that occurs when HDAC6 activity 
is lost. We concluded that the localization of Cx43 could have been altered indirectly, through 
increased acetylation of another HDAC6 substrate. 
Taken together, our results and the results of the aforementioned studies of HDAC 
inhibition and connexins reveal that the physiological consequences of acetylation are likely to 
vary among members of the connexin protein family. It is possible that both Cx32 and Cx43 
proteins are stabilized by acetylation through a decrease in ubiquitination that is caused by 
competition for lysine occupancy. Our work shows that the turnover of WT Cx32 in the presence 
of HDAC6 inhibitor and the turnover of 5Q(acetylation mimetic) Cx32 are both decreased as 
compared to the WT control.  Cx32 ubiquitination is also decreased in both of these cases. The 
impact of acetylation on ubiquitination and turnover of Cx43 have not been investigated, but 
since Henkens et al.(Henkens, Vinken et al. 2008) did show that Cx43 protein accumulated with 
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HDAC inhibition, it is possible that Cx43 stability is also regulated by acetylation. However, 
acetylation often modulates protein-protein interactions that are independent of ubiquitination 
(Spange, Wagner et al. 2009). The putative acetylation sites that have been identified in Cx43 
and Cx32 do not share sequence homology, but are all located in cytoplasmic domains. The  
cytoplasmic location of the residues suggests that they are accessible to interacting proteins and 
the lack of sequence homology suggests that the interacting proteins are likely to be different for 
Cx32 versus Cx43. Also, Cx43 and Cx32 do not form heteromeric channels together and are 
often expressed in different tissues(Elfgang, Eckert et al. 1995; Oyamada, Oyamada et al. 2005). 
 
Questions for Future Investigation 
How does Cx32 acetylation regulate the growth of cell cultures? 
 We observed that transfection with a plasmid encoding 5Q Cx32 resulted in a 
significantly lower cell count compared to cells transfected with 5R or WT Cx32 or the empty 
vector. Based upon this result we concluded that 5Q Cx32 was acting as a negative regulator of 
cell culture growth, but we did not address whether this occurred due to decreased cell division 
or increased cell death.  Future studies should include assays to compare the proliferation rates of 
cells expressing WT, 5R, or 5Q Cx32 or the empty vector. If cells expressing 5Q Cx32 are 
dividing at the same rate as WT and 5R Cx32 expressing cells, then apoptosis is likely to be the 
cause of the reduced cell number and should assayed.  
 Since the growth regulating function of 5Q Cx32 was associated with increased Cx32 at 
the cell surface, we hypothesized that increased Cx32 GJ or hemichannel function was regulating 
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cell division and/or death.  5Q Cx32 GJ function was not altered compared to WT. This was 
assayed by measuring trans-junctional voltage, which is interpreted as a measure of total GJ 
activity per cell pair.  It is not clear if our system would have registered an increase in trans-
junctional voltage compared to the already high WT level, due to high levels of Cx32 expression 
in all of our transiently transfected cells. Based on this uncertainty, we cannot rule out altered 
GJ-mediated communication as a regulator of cell division or death, though hemichannel 
function or altered interactions with cytoplasmic protein partners are other potential 
explanations. 
We could test the contribution of GJ function to the altered cell division or apoptosis that 
we observed by repeating the cell count experiments while treating cells with a Cx32 specific GJ 
inhibitor (Patel, Milwid et al. 2012). If increased GJ function is responsible for the reduced cell 
number after 72 hours of 5Q Cx32 expression, then we would expect that treatment with the 
Cx32 GJ inhibitor would eliminate the observed difference in cell number caused by 5Q Cx32 
expression, compared to WT.  This inhibitor may also block Cx32 hemichannels, so if it reverses 
5Q Cx32 mediated growth inhibition, we would still need to assay the contribution of 
hemichannel function. 
Treatment with a peptide that specifically inhibits Cx32 hemichannels (De Vuyst, 
Decrock et al. 2006) could be used to assay the contribution of Cx32 hemichannels to the 5Q 
Cx32 mediated inhibition of cell culture expansion. Finally, it is possible that neither 
hemichannel nor GJ activity regulates cell division or death through 5Q Cx32. Instead, altered 
protein-protein interactions that occur as a result of the mutations could be in involved in 
signaling pathways that regulate cell division or apoptosis. If this is the case, proteomic 
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comparisons of the interacting factors of WT Cx32 and 5Q Cx32 or WT Cx32 + HDAC6 
inhibitor treatment would provide mechanistic insight. 
Does acetylation occur on residues outside of the C-terminus of Cx32? 
 We found that both 5R and 5Q Cx32 were still acetylated, though the predicted C-
terminal acetylation sites were no longer available for acetylation. As discussed in Chapter 3. of 
this thesis, it is possible that compensatory acetylation of other residues occurs when the normal 
acetylation sites are unavailable. Another possibility is that we were detecting other 
physiologically relevant acetylation sites. In order to address these possibilities, Cx32 acetylation 
sites could be identified using mass spectroscopy.  Use of mass spectroscopy to identify 
acetylation sites depends on being able to affinity purify large quantities of the target protein in 
its acetylated state. Identification of the acetyltransferase responsible for Cx32 acetylation could 
aid in this process because we could either overexpress it in Cx32 expressing cells or use it in an 
in vitro acetylation assay in order to enrich acetylated Cx32 in the sample. Identification of the 
normally occurring Cx32 acetylation sites would validate our results and could also provide 
information about acetylation sites that are not regulated by HDAC6.  Additional acetylation 
may regulate properties of Cx32 that were overlooked by our initial experiments. 
Which acetyltransferases mediate Cx32 acetylation? 
Identifying the enzymes responsible for Cx32 acetylation will provide tools for future 
experiments that involve the manipulation of Cx32 acetylation and also could provide clues as to 
the physiological cues that regulate Cx32 acetylation. P300/CBP-associated factor (PCAF) has 
been shown to acetylate Cx43 (Colussi, Rosati et al. 2011) and thus seems like a good starting 
point when screening for acetyltransferases that modify Cx32. Treating Cx32 expressing cells 
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with the PCAF specific activator, SPV106, would be a simple test to see if PCAF acetylates 
Cx32. If SPV106 fails to enhance Cx32 acetylation, further screening for enhancement of Cx32 
acetylation could be conducted via overexpression and pharmacological inhibition of known 
cytoplasmic acetyltransferases such as alpha-Tat-1, p300, and ELP1.  
Recent work has shown that lysine-acetylation can occur within the lumen of the 
endoplasmic reticulum (ER) as well(Costantini, Ko et al. 2007; Pehar, Lehnus et al. 2012). 
Acetyl Co-A is transported to the ER and there are least two ER resident acetyltransferases, 
which have a growing list of substrates(Ko and Puglielli 2009). Perhaps Cx32 acetylation occurs 
in the ER prior to hemichannel assembly, which takes place in the Golgi (Martin, Blundell et al. 
2001). Acetylation within the ER could be involved in the stabilization of monomeric Cx32, 
which could influence hemichannel formation. Our experiments were carried out with transiently 
transfected cells that produced a high level of Cx32, so it is not clear if we could have detected 
reduced, but not entirely defective, hemichannel formation. We did find that Brefeldin-A 
treatment, which sequesters secretory proteins in the ER, did not prevent Cx32 acetylation. This 
could have been because acetylated Cx32 was trapped in the ER due to retrograde transport from 
elsewhere in the secretory system or because nascent Cx32 is acetylated in the ER. The 
possibility of ER based acetylation has been  recognized only recently and has not been  
investigated as a potential regulator of Cx32 or Cx43. Identifying the enzymes that regulate 
Cx32 acetylation will provide further insight as to whether there  is overlap between the 




Do deacetylases other than HDAC6 target Cx32? 
Co-localization and co-immunoprecipitation studies suggested that HDACs 3,4, and 5 
form a complex that deacetylates Cx43 (Colussi, Rosati et al. 2011). HDAC3 in particular 
localizes at the plasma membrane (Longworth and Laimins 2006) and thus could be another 
Cx32 deacetylase. Depending upon the regulatory role of Cx32 deacetylation, it is possible that 
both cytoplasmic and plasma membrane associated deacetylases could work on Cx32. 
Deacetylase recruitment to Cx32 could result in altered protein-protein interactions that play 
different regulatory roles depending on the deacetylase involved. Also, the acetylation status of 
Cx32 could play different roles depending on the localization of Cx32. Co-immunoprecipitation 
and confocal microscopy could be used to probe putative interactions between Cx32 and 
HDAC3,4,5 as well. 
 
Does acetylation regulate connexin function in a tissue specific manner? 
Reconciling the basic topological and functional redundancy of connexin channels with 
the existence of at least 20 different connexin genes in mammals raises questions about the 
unique properties of different connexin proteins. GJ and non-junctional hemichannel 
composition influence the physiological cues that cells are able to generate and respond to. Each 
combination of connexins forms channels with specific permeability characteristics (White, 
Bruzzone et al. 1994; Koval, Geist et al. 1995; Sosinsky 1995; Martinez, Hayrapetyan et al. 
2002) . Also, each connexin has a specific repertoire of cytoplasmic interacting factors that 
provide links to signaling pathways that are both dependent upon and independent of cell-cell 
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communication (Giepmans, Verlaan et al. 2001; Duffy, Iacobas et al. 2007; Chakraborty, Mitra 
et al. 2010).  
Experiments comparing the function of GJ composed of different connexins in a GJ 
deficient background support the premise that while functional conservation exists, different 
connexins confer unique, physiologically relevant properties to the GJ that they form. For 
example, germline deletion of Cx43 results in lethal cardiovascular defects (Ya, Erdtsieck-Ernste 
et al. 1998) . Replacement of the Cx43 gene with either Cx32 or Cx40 rescued viability, but the 
resulting transgenic mice had various morphological defects (Plum, Hallas et al. 2000). The 
morphological defects that resulted from the gene replacements were not as severe as the Cx43 
deletion, but included mild heart defects and other, defects that were unique depending on the 
replacing connexin. This study suggests that different connexins have both shared and unique 
functions within tissues.  
Interestingly, overexpression of Cx43 also caused  heart and neural tube defects, 
suggesting that temporal regulation of connexin protein level is important during morphogenesis 
(Ewart, Cohen et al. 1997). Reduced GJ mediated cell-cell coupling can protect tissues from 
injury (Frantseva, Kokarovtseva et al. 2002), but enhances tumor cell proliferation (Omori, 
Zaidan Dagli et al. 2001).Studies of inherited connexin mutations within human populations also 
provide evidence for the conserved and unique roles of connexins in specific tissues. For 
example, hereditary Cx32 mutations that cause loss of GJ function  result in demyelinating 
neuropathy (Abrams, Freidin et al. 2001). Similarly, mutations that reduce Cx43GJ function  
result in developmental defects in the patterning of bones, skin, and eyes (Shibayama, Paznekas 
et al. 2005). In both of these cases, many tissues remain unaffected since they do not depend 
upon the mutated connexins for proper cell-cell communication. Taken together, these studies 
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indicate that the spatial and temporal regulation of GJ activity must be tightly regulated to 
maintain tissue homeostasis. 
Cell type specific GJ and connexin hemichannel composition is dependent upon the 
transcriptional regulation of connexin genes (Oyamada, Oyamada et al. 2005), as well as later 
regulatory events that modulate the assembly of connexin hemichannels, hemichannel trafficking 
to the plasma membrane, and  cell surface connexin dynamics.  Our results add to a growing 
body of evidence that post-translational modifications could be involved in regulating the cell 
type specific composition of connexin hemichannels and GJ by influencing the localization and 
turnover of connexins. Acetylation  seems to act as a negative regulator of Cx43 GJs (Colussi, 
Rosati et al. 2011) , while our data indicate that acetylation is likely to enhance the function of 
Cx32 at the cell surface . Recent proteomic studies have suggested that acetylation  occurs in a 
tissue specific manner (Spange, Wagner et al. 2009) and can be linked to metabolism (Zhao, Xu 
et al. 2010).  Thus, it is possible that tissue specific activity of the enzymes that mediate lysine 
acetylation and deacetylation could be involved in regulating the fate of expressed connexin 
proteins.  Connexins that are positively regulated by acetylation could be the major mediators of 
GJ mediated cell-cell communication in cells that have high levels of the appropriate 
acetyltransferase activity and/or low levels of the appropriate HDAC activity.  
We hypothesize that the maintenance of functional hemichannels or GJ composed of a 
particular connexin can be regulated through the expression and modulation of acetyltransferase 
and HDAC activity.  Future studies should probe the acetylation of connexins under various 
physiological conditions in order to determine if there are certain conditions that promote 
connexin acetylation. Based on our Cx32 results and Cx43 acetylation studies conducted in other 
laboratories, we predict that altering global acetylation will have connexin and thus tissue 
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specific effects on GJ-mediated communication. Also, proteomic comparisons of connexin 
interacting partners under high and low acetylation conditions should provide mechanistic 
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